{"gene":"PRTN3","run_date":"2026-04-28T19:45:45","timeline":{"discoveries":[{"year":1989,"finding":"PRTN3 (proteinase 3/myeloblastin) was identified as a novel neutrophil serine proteinase and the target autoantigen of c-ANCA autoantibodies in Wegener's granulomatosis. The 29-kDa protein was purified from neutrophils, showed a novel N-terminal sequence homologous to serine proteinases, and bound radiolabeled diisopropyl fluorophosphate, confirming serine protease activity.","method":"Affinity purification, Western blot, monoclonal antibody generation, N-terminal sequencing, DFP binding assay","journal":"Blood","confidence":"High","confidence_rationale":"Tier 1 — in vitro enzymatic characterization, multiple orthogonal methods, foundational discovery replicated across labs","pmids":["2679910"],"is_preprint":false},{"year":1989,"finding":"PRTN3 (myeloblastin) expression is down-regulated during induced differentiation of HL-60 promyelocytic leukemia cells, and antisense oligodeoxynucleotide-mediated inhibition of myeloblastin expression inhibits proliferation and induces differentiation, demonstrating a functional role for PRTN3 in maintaining the proliferative state of myeloid progenitor cells.","method":"Antisense oligodeoxynucleotide knockdown, flow cytometry, Northern blot, cell proliferation assays","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 — functional loss-of-function with defined cellular phenotype (growth arrest and differentiation), replicated with multiple inducers","pmids":["2598267"],"is_preprint":false},{"year":1990,"finding":"PRTN3 cDNA was cloned from human bone marrow, revealing a primary structure with high homology to elastase, cathepsin G, and other serine proteases. The protein contains the catalytic triad and elastase-like substrate binding pocket, is more abundant in neutrophils than elastase, and has a similar proteolytic profile. It is encoded by a single gene.","method":"cDNA cloning, N-terminal sequencing, CNBr fragment sequencing, Southern blot","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 1 — definitive structural/sequence characterization with functional validation","pmids":["2258701"],"is_preprint":false},{"year":1990,"finding":"The autoantigen of anti-neutrophil cytoplasm antibodies (ANCA) in Wegener's granulomatosis was identified as proteinase 3, an elastinolytic neutral serine proteinase isolated by affinity chromatography from degranulated neutrophils, with 17 NH2-terminal amino acids showing homology to serine proteinases.","method":"Affinity chromatography, phorbol ester-induced neutrophil degranulation, N-terminal sequence analysis, elastinolytic activity assay","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 1 — biochemical purification and enzymatic characterization, foundational paper (424 citations)","pmids":["1688612"],"is_preprint":false},{"year":1990,"finding":"The Wegener's granulomatosis autoantigen was decoded as proteinase 3, a member of the serine proteinase family.","method":"Biochemical characterization, sequence analysis","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 — foundational identification, highly cited","pmids":["2377228"],"is_preprint":false},{"year":1991,"finding":"PRTN3 was biochemically characterized as a serine proteinase with elastase-like specificity (preference for small aliphatic amino acids at P1 site: alanine, serine, valine). It degrades extracellular matrix proteins including fibronectin, laminin, vitronectin, and collagen type IV but not interstitial collagens I and III. It is inhibited by alpha1-proteinase inhibitor and alpha2-macroglobulin but NOT by secretory leukoprotease inhibitor or alpha1-antichymotrypsin, distinguishing it from elastase and cathepsin G.","method":"In vitro enzymatic assays with chromogenic substrates and matrix proteins, inhibitor profiling, peptide substrate analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — detailed in vitro reconstitution with multiple substrates, rigorous inhibitor profiling","pmids":["2033050"],"is_preprint":false},{"year":1992,"finding":"The genes for PRTN3 (PR3), neutrophil elastase (NE), and azurocidin (AZU) are organized as a single genetic locus on chromosome 19pter, with PR3 separated by 8 kb from AZU and 3 kb from NE. All three genes are coordinately down-regulated during terminal differentiation of the premonocytic cell line U937, and share the same five-exon structure typical of granule-associated serine proteases.","method":"Cosmid cloning, FISH, physical mapping, exon-intron analysis, Northern blot during differentiation","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — definitive genomic organization with functional validation of coordinate expression","pmids":["1518849"],"is_preprint":false},{"year":1993,"finding":"C-ANCA (anti-PR3 antibodies) interfere with PR3 proteolytic activity and inhibit complexation of PR3 with its major physiologic inhibitor alpha1-antitrypsin (alpha1-AT). The degree of C-ANCA inhibition of PR3-alpha1-AT complexation correlates with disease activity in Wegener's granulomatosis, whereas C-ANCA titer alone does not.","method":"Serial serum sample analysis, PR3-alpha1-AT complexation assay, disease activity scoring, correlation analysis","journal":"Clinical and experimental immunology","confidence":"Medium","confidence_rationale":"Tier 2 — functional inhibition assay with clinical correlation; single lab","pmids":["8370167"],"is_preprint":false},{"year":1994,"finding":"Anti-PR3 antibodies (C-ANCA) recognize PR3 translocated to the membrane of TNF-alpha-treated human endothelial cells and mediate cytotoxicity against those cells in a complement-independent manner requiring co-cultivation with cytokine-primed neutrophils. Cytotoxicity was measured by Cr-release assay and was inhibited by preincubation with purified PR3 antigen.","method":"Chromium release cytotoxicity assay, affinity-purified antibodies, TNF-alpha priming of endothelial cells, neutrophil co-culture","journal":"Clinical and experimental immunology","confidence":"Medium","confidence_rationale":"Tier 2 — functional cellular assay with defined mechanistic controls; single lab","pmids":["8082300"],"is_preprint":false},{"year":1995,"finding":"PR3 enzymatically cleaves human IgG of all subclasses, including C-ANCA IgG complexed to the enzyme. Cleavage products differ from those generated by neutrophil elastase, demonstrating a distinct proteolytic specificity of PR3 toward immunoglobulins.","method":"In vitro proteolysis assay, gel electrophoresis analysis of cleavage products, comparison with human neutrophil elastase","journal":"Clinical and experimental immunology","confidence":"Medium","confidence_rationale":"Tier 1 — in vitro enzymatic assay; single lab, moderate follow-up","pmids":["7621597"],"is_preprint":false},{"year":1996,"finding":"The crystal structure of PR3 was solved at 2.2 Å resolution by molecular replacement. The overall fold consists of two beta-barrel domains typical of the chymotrypsin family. The substrate binding site S1 pocket is defined by a Val-to-Ile substitution at position 190 (explaining preference for small aliphatic P1 residues) and Ala-to-Asp substitution at position 213. An N-linked disaccharide is attached to Asn159. Linear antigenic sites reactive with Wegener's granulomatosis autoantibodies map to surface-accessible regions, implicating the pro-form in pathogenesis.","method":"X-ray crystallography at 2.2 Å, molecular replacement, structural refinement (R=0.201)","journal":"Journal of molecular biology","confidence":"High","confidence_rationale":"Tier 1 — crystal structure with functional residue interpretation, highly cited foundational structure","pmids":["8757293"],"is_preprint":false},{"year":1998,"finding":"The mouse Prtn3 gene was characterized and mapped by FISH to chromosome 10C2, in close proximity to the neutrophil elastase gene (Ela2). The gene consists of five exons and four introns, conserving the typical granule-associated serine protease structure. The proximal promoter contains a TATA box, c-myb, and ets transcriptional sites. Mouse and human PR3 cDNA share 73% homology (60% at amino acid level); the catalytic triad and placement are conserved.","method":"FISH analysis, gene structure characterization, promoter analysis, cDNA sequence comparison","journal":"Cytogenetics and cell genetics","confidence":"Medium","confidence_rationale":"Tier 2 — definitive genomic localization and structural characterization; single study","pmids":["9925946"],"is_preprint":false},{"year":1999,"finding":"PR3 is present not only in azurophil granules but also in specific granules and in secretory vesicles (the most readily mobilizable intracellular pool), distinct from elastase and myeloperoxidase which are exclusively in azurophil granules. Upon FMLP stimulation, membrane PR3 expression increases in a sequential manner: secretory vesicles first, followed by specific granules, then azurophil granules. Membrane association of PR3 appears covalent (not ionic).","method":"Subcellular fractionation, immunoelectron microscopy, FACS analysis of membrane PR3 after FMLP stimulation, comparison with elastase and myeloperoxidase","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal localization methods (fractionation + EM + flow cytometry) with functional mobilization data","pmids":["10498622"],"is_preprint":false},{"year":1999,"finding":"PR3 induces IL-8 production in TNF-alpha/IL-1beta-activated endothelial cells through activation of NF-kappaB. Anti-PR3 antibodies acting on membrane-expressed PR3 amplify this response. NF-kappaB activation was confirmed by PAGE of nuclear extracts and Western blot for p65.","method":"RT-PCR, ELISA, NF-kappaB activation assay, cycloheximide inhibition, monoclonal anti-PR3 antibody (WGM2)","journal":"European journal of clinical investigation","confidence":"Medium","confidence_rationale":"Tier 2 — mechanistic signaling pathway identified with multiple methods; single lab","pmids":["10583443"],"is_preprint":false},{"year":1999,"finding":"Purified PR3 (but not neutrophil elastase or cathepsin G) is responsible for converting enzyme-independent release of bioactive TNF-alpha and IL-1beta from LPS-stimulated monocytic cells (THP-1). This was demonstrated using specific inhibitors and purified enzymes, identifying an alternative cytokine processing pathway in local inflammatory contexts.","method":"Neutrophil-monocyte co-culture, specific serine protease inhibitors, purified enzymes (PR3, NE, Cat G), ELISA for TNF-alpha and IL-1beta","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — reconstituted with purified enzyme plus specific inhibitor controls, replicated with multiple approaches","pmids":["10339575"],"is_preprint":false},{"year":2001,"finding":"Proteinase 3 is solely responsible for cleavage of the human cathelicidin hCAP-18 to generate the active antimicrobial peptide LL-37 after neutrophil exocytosis. Immunoelectron microscopy showed both hCAP-18 and azurophil granule proteins in phagolysosomes. Cleavage of hCAP-18 to LL-37 occurred only in exocytosed material, not after phagocytosis.","method":"Immunoelectron microscopy, immunoblotting, comparison of NE/PR3/cathepsin G with purified enzymes, subcellular fractionation","journal":"Blood","confidence":"High","confidence_rationale":"Tier 1 — definitive assignment of enzymatic cleavage role with purified enzymes and multiple orthogonal methods","pmids":["11389039"],"is_preprint":false},{"year":2001,"finding":"Neutrophil proteinase 3 (PR3) induces secretion of bioactive IL-18 (active 18-kDa form) from human oral epithelial cells via a caspase-1-independent pathway, following IFN-gamma priming plus LPS co-stimulation. PR3 was detected only in membrane fractions (not cytoplasm) of treated cells, and induction was blocked by serine proteinase inhibitors but not caspase-1 inhibitors.","method":"Cell stimulation assays, Western blot for IL-18 isoforms, caspase-1 inhibitor controls, serine proteinase inhibitors, subcellular fractionation, RT-PCR, IFN-gamma bioassay","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 1 — mechanistic identification of caspase-1-independent IL-18 processing pathway with rigorous controls","pmids":["11714826"],"is_preprint":false},{"year":2002,"finding":"Proteinase 3 is strongly expressed in lung parenchymal cells (type I and II pneumocytes) and macrophages in Wegener's granulomatosis tissue, as well as in normal lung tissue (though up-regulated in WG). This non-neutrophil expression pattern suggests these cells may contribute to lung damage via direct interaction with ANCA.","method":"Immunohistochemistry of lung biopsies from WG patients and normal tissue","journal":"Arthritis research","confidence":"Low","confidence_rationale":"Tier 3 — localization by IHC without direct functional consequence established","pmids":["12010574"],"is_preprint":false},{"year":2002,"finding":"Neutrophil membrane expression of PR3 (mPR3) is related to relapse in PR3-ANCA-associated vasculitis. An elevated percentage and level of mPR3 expression on resting neutrophils of WG patients significantly associated with increased relapse risk and relapse rate, but not with disease extent or particular manifestations.","method":"FACS analysis of membrane PR3 in 89 WG patients and 72 healthy controls, clinical follow-up analysis","journal":"Journal of the American Society of Nephrology","confidence":"Medium","confidence_rationale":"Tier 2 — defined cellular phenotype (membrane localization) linked to clinical outcome in sizable cohort","pmids":["12191967"],"is_preprint":false},{"year":2003,"finding":"Neutrophil membrane PR3 (mPR3) expression is genetically determined. Twin studies demonstrated near-perfect concordance of mPR3 expression in monozygotic twins (r=0.99) versus dizygotic twins (r=0.06). Critically, mPR3 expression is independent of intracellular PR3 content, indicating that membrane targeting rather than total protein level is under genetic control.","method":"FACS analysis, monozygotic vs. dizygotic twin study (27 pairs), intracellular flow cytometry, Western blotting, FACSort-separated subpopulation analysis","journal":"Journal of the American Society of Nephrology","confidence":"High","confidence_rationale":"Tier 2 — elegant twin study design with orthogonal intracellular measurements, strong genetic evidence","pmids":["12506139"],"is_preprint":false},{"year":2005,"finding":"Anti-PR3 antibodies (C-ANCA) prime monocytes and neutrophils for enhanced CD14-dependent activation, resulting in markedly augmented IL-8, TNF-alpha, and IL-6 release upon subsequent LPS or LTA (but not TNF-alpha) challenge. Priming was associated with increased CD14 membrane expression and required 2-6 hours of anti-PR3 pre-incubation.","method":"In vitro monocyte/neutrophil stimulation, ELISA for cytokines, flow cytometric analysis of CD14 expression, isotype-matched IgG controls, ANCA-IgG from WG serum","journal":"Journal of leukocyte biology","confidence":"Medium","confidence_rationale":"Tier 2 — mechanistic cellular pathway identified with multiple cytokine readouts and CD14 expression data; single lab","pmids":["16006536"],"is_preprint":false},{"year":2006,"finding":"Proteinase 3 (PR3) was identified as a specific binding protein for the proinflammatory cytokine IL-32alpha, with dissociation constants of 2.65 nM (urinary PR3) and 1.2 nM (neutrophil-derived PR3) determined by surface plasmon resonance. Irreversible inactivation of PR3 enzymatic activity did not significantly change IL-32 binding, establishing a non-catalytic binding function. However, limited cleavage of IL-32alpha by PR3 enhanced its cytokine activity (MIP-2 and IL-8 induction) more than intact IL-32alpha.","method":"IL-32alpha affinity chromatography, mass spectrometry identification, N-terminal microsequencing, surface plasmon resonance, enzymatic inactivation, cytokine induction assays in mouse macrophages and human PBMCs","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — biochemical binding characterized by SPR, enzymatic activity separately assessed, functional consequences demonstrated with reconstituted system","pmids":["16488976"],"is_preprint":false},{"year":2008,"finding":"ANCA patients with PR3-ANCA have CD4+ TH1 memory T cells responsive to the complementary-PR3 (cPR3) protein encoded by the antisense strand of the PR3 gene. Approximately half of PR3-ANCA patients had cPR3(138-169)-peptide-reactive T cells, whereas MPO-ANCA patients did not, indicating specificity. The HLA-DRB1*15 allele was overrepresented and predicted to bind cPR3(138-169) with high affinity.","method":"Memory T cell cultivation, proliferation assays, IFN-gamma secretion assays, HLA-DRB1 typing, peptide binding prediction","journal":"Kidney international","confidence":"Medium","confidence_rationale":"Tier 2 — functional T cell responses characterized with specificity controls; supports complementary protein autoimmunity model","pmids":["18596726"],"is_preprint":false},{"year":2017,"finding":"A genome-wide association study identified a functional variant at the PRTN3 locus in which the top-scoring SNP correlated with increased PRTN3 expression in neutrophils, contributing to susceptibility to ANCA-associated vasculitis (granulomatosis with polyangiitis). The overall population attributable fraction for identified variants including PRTN3, HLA-DPB1, SERPINA1, and PTPN22 was 77%.","method":"GWAS in 1,986 AAV cases and 4,723 controls, functional annotation, eQTL analysis of neutrophil gene expression","journal":"Arthritis & rheumatology","confidence":"Medium","confidence_rationale":"Tier 2 — eQTL analysis linking genetic variant to PRTN3 expression in primary neutrophils; large well-powered study","pmids":["28029757"],"is_preprint":false},{"year":2019,"finding":"SERPINB1 limits the activity of neutrophil serine proteases (including PR3) through its reactive center loop and separately constrains inflammatory caspase (caspase-1/-4/-5/-11) activation through a C-terminal CARD-binding motif. Knockdown or deletion of SERPINB1 caused spontaneous caspase-1/-4/-5/-11 activation, IL-1β release, and pyroptosis, establishing SERPINB1 as a checkpoint for both PR3 activity and inflammatory caspase activation through genetically and functionally separable mechanisms.","method":"SERPINB1 knockout mice, siRNA knockdown, IL-1β ELISA, pyroptosis assays, domain mutagenesis, in vitro protease activity assays","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 1 — genetic knockout combined with domain mutagenesis and functional assays; rigorous mechanistic dissection","pmids":["30692621"],"is_preprint":false},{"year":2021,"finding":"PRTN3 (proteinase 3), along with cathepsin G and neutrophil elastase, catalyzes proteolytic cleavage of the histone H3 amino terminus (H3ΔN) in human peripheral blood monocytes. This histone mark is repressed as monocytes differentiate into macrophages. Simultaneous NSP depletion in monocytic cells causes H3ΔN loss and increased chromatin accessibility, priming chromatin for gene expression reprogramming during monocyte-to-macrophage differentiation. H3ΔN is enriched at permissive chromatin and actively transcribed genes.","method":"NSP depletion, integrative epigenomic analysis (ChIP-seq, ATAC-seq), primary monocyte/macrophage differentiation, patient monocytes from systemic JIA, quantitative histone cleavage assays","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 1 — mechanistic epigenomic study with NSP depletion, multiple genome-wide assays, and disease-relevant patient samples","pmids":["34017121"],"is_preprint":false},{"year":2023,"finding":"Fusobacterium nucleatum promotes esophageal squamous cell carcinoma proliferation by upregulating expression of IL-32 and PRTN3, subsequently activating the PI3K/AKT signaling pathway. This was demonstrated in vitro and in vivo.","method":"In vitro proliferation assays, in vivo tumor models, FISH, RT-PCR, pathway analysis","journal":"Cancer science","confidence":"Low","confidence_rationale":"Tier 3 — PRTN3 upregulation identified but direct mechanistic role of PRTN3 protein in PI3K/AKT activation not established by direct biochemical experiment","pmids":["36919771"],"is_preprint":false}],"current_model":"PRTN3 encodes proteinase 3 (PR3/myeloblastin), a neutrophil serine proteinase stored primarily in azurophil granules (and also in secretory vesicles, a highly mobilizable pool) that degrades extracellular matrix proteins with elastase-like specificity (preference for small aliphatic P1 residues), is inhibited by alpha1-antitrypsin and alpha2-macroglobulin but not SLPI, cleaves hCAP-18 to generate the antimicrobial peptide LL-37, processes TNF-alpha and IL-1beta via a converting enzyme-independent pathway, binds IL-32alpha with nanomolar affinity (independent of catalytic activity) while also proteolytically enhancing IL-32 bioactivity, catalyzes histone H3 N-terminal cleavage (H3ΔN) in monocytes to regulate chromatin accessibility during monocyte-to-macrophage differentiation, and whose expression level is genetically regulated (membrane expression controlled independently of intracellular content), with expression suppression by antisense approaches causing growth arrest and differentiation of myeloid progenitor cells."},"narrative":{"teleology":[{"year":1989,"claim":"Identification of PR3 as a novel neutrophil serine proteinase and the c-ANCA autoantigen in Wegener's granulomatosis established the molecular identity of the protein and its disease relevance simultaneously.","evidence":"Affinity purification from neutrophils, DFP binding, N-terminal sequencing, Western blot with monoclonal antibodies","pmids":["2679910","2377228"],"confidence":"High","gaps":["Enzymatic specificity and substrate repertoire not yet defined","Subcellular localization beyond azurophil granules unknown","No structural model available"]},{"year":1989,"claim":"Demonstrating that antisense suppression of myeloblastin causes growth arrest and differentiation of myeloid progenitors revealed a non-proteolytic role in maintaining the proliferative state of myeloid cells.","evidence":"Antisense oligodeoxynucleotide knockdown in HL-60 cells with proliferation and differentiation assays","pmids":["2598267"],"confidence":"High","gaps":["Mechanism linking PR3 expression to proliferative maintenance not elucidated","Whether catalytic activity is required for this function is unknown"]},{"year":1991,"claim":"Biochemical characterization of PR3's substrate specificity (preference for small aliphatic P1 residues) and inhibitor profile (inhibited by α1-antitrypsin and α2-macroglobulin but not SLPI) distinguished it from neutrophil elastase and cathepsin G, defining its unique proteolytic niche.","evidence":"In vitro enzymatic assays with chromogenic substrates, ECM protein degradation, inhibitor profiling","pmids":["2033050"],"confidence":"High","gaps":["In vivo substrates beyond ECM not yet identified","Physiological contexts of proteolysis unclear"]},{"year":1992,"claim":"Mapping the PRTN3/ELA2/AZU locus on chromosome 19pter and demonstrating coordinate down-regulation during differentiation established the genomic organization and transcriptional co-regulation of neutrophil serine protease genes.","evidence":"Cosmid cloning, FISH, Northern blot during U937 differentiation","pmids":["1518849"],"confidence":"High","gaps":["Specific promoter elements driving PR3 transcription not fully defined","Whether coordinate regulation extends to protein-level control unknown"]},{"year":1996,"claim":"The 2.2 Å crystal structure revealed the chymotrypsin-fold architecture and the S1 pocket residues (Val190→Ile, Ala213→Asp) that dictate small aliphatic P1 preference, providing the first structural explanation for PR3's distinctive specificity.","evidence":"X-ray crystallography at 2.2 Å resolution with molecular replacement","pmids":["8757293"],"confidence":"High","gaps":["No substrate-bound or inhibitor-bound co-crystal structures","Structural basis for membrane association not addressed"]},{"year":1999,"claim":"Discovery that PR3 is stored in secretory vesicles (the most mobilizable pool) in addition to azurophil granules, and that membrane PR3 increases sequentially upon stimulation, resolved how PR3 reaches the cell surface and distinguished its trafficking from elastase.","evidence":"Subcellular fractionation, immunoelectron microscopy, FACS after fMLP stimulation","pmids":["10498622"],"confidence":"High","gaps":["Molecular mechanism of membrane anchoring (apparently covalent) not identified","Sorting signal directing PR3 to secretory vesicles unknown"]},{"year":1999,"claim":"Identification of PR3 as a converting enzyme–independent processor of TNF-α and IL-1β from monocytic cells established an alternative pro-inflammatory cytokine activation pathway distinct from TACE and caspase-1.","evidence":"Neutrophil-monocyte co-culture with purified PR3, specific serine protease inhibitors, ELISA","pmids":["10339575"],"confidence":"High","gaps":["Cleavage sites on TNF-α and IL-1β not mapped","Relative contribution versus canonical processing in vivo unknown"]},{"year":2001,"claim":"PR3 was identified as the sole protease responsible for cleaving hCAP-18 to generate the antimicrobial peptide LL-37 after neutrophil exocytosis, establishing a specific antimicrobial effector function.","evidence":"Immunoelectron microscopy, comparison of purified NE/PR3/cathepsin G, immunoblotting of exocytosed material","pmids":["11389039"],"confidence":"High","gaps":["Whether PR3 processes other antimicrobial precursors unknown","In vivo validation in infection models not reported"]},{"year":2003,"claim":"Twin studies demonstrating that membrane PR3 expression is genetically determined (r=0.99 in monozygotic twins) and independent of intracellular PR3 content revealed that membrane targeting is under separate genetic control, explaining inter-individual variation in ANCA-vasculitis susceptibility.","evidence":"FACS in 27 monozygotic vs. dizygotic twin pairs, intracellular flow cytometry, Western blot","pmids":["12506139"],"confidence":"High","gaps":["Causal genetic variant(s) controlling membrane targeting not identified at this time","Whether membrane PR3 has distinct functional properties versus granule PR3 unknown"]},{"year":2006,"claim":"Demonstration that PR3 binds IL-32α with nanomolar affinity independent of catalytic activity, while also proteolytically enhancing IL-32 bioactivity, revealed a dual catalytic/non-catalytic mechanism for amplifying cytokine signaling.","evidence":"Surface plasmon resonance, enzymatic inactivation, IL-32α affinity chromatography, cytokine induction assays","pmids":["16488976"],"confidence":"High","gaps":["Structural basis for non-catalytic IL-32 binding unknown","In vivo relevance of PR3–IL-32 axis not established"]},{"year":2017,"claim":"A GWAS identified a functional PRTN3 locus variant that increases neutrophil PRTN3 expression and contributes to ANCA-associated vasculitis susceptibility, providing the genetic link between expression level and disease risk.","evidence":"GWAS in 1,986 AAV cases and 4,723 controls with eQTL analysis in primary neutrophils","pmids":["28029757"],"confidence":"Medium","gaps":["Specific causal variant and regulatory mechanism not fully resolved","How expression level interacts with membrane targeting genetics is unclear"]},{"year":2019,"claim":"Identification of SERPINB1 as a dual checkpoint that limits PR3 activity via its reactive center loop and independently constrains inflammatory caspases via a CARD-binding motif placed PR3 within a broader intracellular protease control network.","evidence":"SERPINB1 knockout mice, domain mutagenesis, siRNA knockdown, protease activity and IL-1β release assays","pmids":["30692621"],"confidence":"High","gaps":["Whether SERPINB1 is the primary intracellular PR3 inhibitor in neutrophils versus monocytes not distinguished","Relative contribution of PR3 versus NE/CatG to SERPINB1-regulated phenotypes not fully separated"]},{"year":2021,"claim":"Discovery that PR3 (with NE and CatG) catalyzes histone H3 N-terminal cleavage in monocytes, regulating chromatin accessibility and gene expression reprogramming during monocyte-to-macrophage differentiation, revealed an unexpected nuclear/epigenomic function.","evidence":"NSP depletion, ChIP-seq, ATAC-seq, primary monocyte differentiation, systemic JIA patient monocytes","pmids":["34017121"],"confidence":"High","gaps":["Individual contribution of PR3 versus NE and CatG to H3ΔN not fully dissected","Mechanism of PR3 nuclear import not established","Whether H3ΔN activity extends to other cell lineages unknown"]},{"year":null,"claim":"The mechanism by which PR3 is targeted to the plasma membrane independently of intracellular content, and the structural determinants of its non-catalytic IL-32 binding, remain unresolved.","evidence":"","pmids":[],"confidence":"High","gaps":["Membrane anchoring mechanism (GPI-anchor versus transmembrane partner) not definitively identified","No co-crystal structure of PR3 with IL-32","In vivo contribution of individual PR3 functions (antimicrobial, cytokine processing, chromatin remodeling) to host defense not separately quantified"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,5,10,14,15,16,21,25]},{"term_id":"GO:0016787","term_label":"hydrolase activity","supporting_discovery_ids":[0,5,9,10]},{"term_id":"GO:0042393","term_label":"histone binding","supporting_discovery_ids":[25]}],"localization":[{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[12]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[12,18,19]},{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[5,15]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[25]}],"pathway":[{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[0,14,15,16,20,24,25]},{"term_id":"R-HSA-1474244","term_label":"Extracellular matrix organization","supporting_discovery_ids":[5]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[25]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[7,18,23]}],"complexes":[],"partners":["IL32","SERPINB1","SERPINA1","CAMP","IL1B","TNF","ELANE","CTSG"],"other_free_text":[]},"mechanistic_narrative":"PRTN3 encodes proteinase 3 (PR3/myeloblastin), a neutrophil serine proteinase with elastase-like specificity that functions as a multifaceted effector of innate immunity, inflammation, and myeloid cell fate. Stored in azurophil granules and secretory vesicles, PR3 degrades extracellular matrix proteins (fibronectin, laminin, vitronectin, collagen IV), generates the antimicrobial peptide LL-37 by cleaving hCAP-18, and processes pro-inflammatory cytokines TNF-α, IL-1β, and IL-18 through converting enzyme/caspase-1–independent pathways [PMID:2033050, PMID:11389039, PMID:10339575, PMID:11714826]. PR3 also binds IL-32α with nanomolar affinity independently of catalytic activity and proteolytically enhances IL-32 bioactivity [PMID:16488976], and catalyzes histone H3 N-terminal cleavage in monocytes to regulate chromatin accessibility during monocyte-to-macrophage differentiation [PMID:34017121]. PR3 is the major target autoantigen of c-ANCA in granulomatosis with polyangiitis (Wegener's granulomatosis), where genetically determined membrane PR3 expression—controlled independently of intracellular content—is a risk factor for disease relapse, and a functional PRTN3 locus variant contributes to disease susceptibility [PMID:2679910, PMID:12506139, PMID:28029757]."},"prefetch_data":{"uniprot":{"accession":"P24158","full_name":"Myeloblastin","aliases":["AGP7","C-ANCA antigen","Leukocyte proteinase 3","PR-3","PR3","Neutrophil proteinase 4","NP-4","P29","Wegener autoantigen"],"length_aa":256,"mass_kda":27.8,"function":"Serine protease that degrades elastin, fibronectin, laminin, vitronectin, and collagen types I, III, and IV (in vitro) (PubMed:2033050, PubMed:28240246, PubMed:3198760). By cleaving and activating receptor F2RL1/PAR-2, enhances endothelial cell barrier function and thus vascular integrity during neutrophil transendothelial migration (PubMed:23202369). Plays a role in neutrophil transendothelial migration, probably when associated with CD177 (PubMed:22266279). Triggers inflammatory processes in neutrophils by interacting with ADGRG3 upstream of F2RL1/PAR2 activation (PubMed:36302784)","subcellular_location":"Cytoplasmic granule; Secreted; Cell membrane; Membrane raft","url":"https://www.uniprot.org/uniprotkb/P24158/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/PRTN3","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/PRTN3","total_profiled":1310},"omim":[{"mim_id":"613107","title":"NEUTROPENIA, SEVERE CONGENITAL, 2, AUTOSOMAL DOMINANT; SCN2","url":"https://www.omim.org/entry/613107"},{"mim_id":"608710","title":"GRANULOMATOSIS WITH POLYANGIITIS; GPA","url":"https://www.omim.org/entry/608710"},{"mim_id":"606599","title":"THIOREDOXIN-INTERACTING PROTEIN; TXNIP","url":"https://www.omim.org/entry/606599"},{"mim_id":"606001","title":"INTERLEUKIN 32; IL32","url":"https://www.omim.org/entry/606001"},{"mim_id":"600953","title":"INTERLEUKIN 18; IL18","url":"https://www.omim.org/entry/600953"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Cytosol","reliability":"Approved"},{"location":"Vesicles","reliability":"Additional"}],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"bone marrow","ntpm":1978.0}],"url":"https://www.proteinatlas.org/search/PRTN3"},"hgnc":{"alias_symbol":["PR-3","ACPA","C-ANCA","AGP7","MBT","P29"],"prev_symbol":[]},"alphafold":{"accession":"P24158","domains":[{"cath_id":"2.40.10.10","chopping":"41-137_240-255","consensus_level":"medium","plddt":96.5479,"start":41,"end":255},{"cath_id":"2.40.10.10","chopping":"151-238","consensus_level":"medium","plddt":92.4467,"start":151,"end":238}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P24158","model_url":"https://alphafold.ebi.ac.uk/files/AF-P24158-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P24158-F1-predicted_aligned_error_v6.png","plddt_mean":89.56},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=PRTN3","jax_strain_url":"https://www.jax.org/strain/search?query=PRTN3"},"sequence":{"accession":"P24158","fasta_url":"https://rest.uniprot.org/uniprotkb/P24158.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P24158/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P24158"}},"corpus_meta":[{"pmid":"16415788","id":"PMC_16415788","title":"Tudor, MBT and chromo domains gauge the degree of lysine methylation.","date":"2006","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/16415788","citation_count":385,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21156761","id":"PMC_21156761","title":"A genome-wide association study suggests contrasting associations in ACPA-positive versus ACPA-negative rheumatoid arthritis.","date":"2010","source":"Annals of the rheumatic diseases","url":"https://pubmed.ncbi.nlm.nih.gov/21156761","citation_count":214,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22293763","id":"PMC_22293763","title":"The influence of ACPA status and characteristics on the course of RA.","date":"2012","source":"Nature reviews. Rheumatology","url":"https://pubmed.ncbi.nlm.nih.gov/22293763","citation_count":175,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25587188","id":"PMC_25587188","title":"Extensive glycosylation of ACPA-IgG variable domains modulates binding to citrullinated antigens in rheumatoid arthritis.","date":"2015","source":"Annals of the rheumatic diseases","url":"https://pubmed.ncbi.nlm.nih.gov/25587188","citation_count":164,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19778625","id":"PMC_19778625","title":"MBT domain proteins in development and disease.","date":"2009","source":"Seminars in cell & developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/19778625","citation_count":123,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29472818","id":"PMC_29472818","title":"The role of anti-citrullinated protein antibodies (ACPA) in the pathogenesis of rheumatoid arthritis.","date":"2017","source":"Central-European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/29472818","citation_count":120,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24831057","id":"PMC_24831057","title":"The lung in ACPA-positive rheumatoid arthritis: an initiating site of injury?","date":"2014","source":"Rheumatology (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/24831057","citation_count":85,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8370167","id":"PMC_8370167","title":"Relevance of classic anti-neutrophil cytoplasmic autoantibody (C-ANCA)-mediated inhibition of proteinase 3-alpha 1-antitrypsin complexation to disease activity in Wegener's granulomatosis.","date":"1993","source":"Clinical and experimental immunology","url":"https://pubmed.ncbi.nlm.nih.gov/8370167","citation_count":84,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21455249","id":"PMC_21455249","title":"Rheumatoid arthritis: Are ACPA-positive and ACPA-negative RA the same disease?","date":"2011","source":"Nature reviews. Rheumatology","url":"https://pubmed.ncbi.nlm.nih.gov/21455249","citation_count":74,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16137613","id":"PMC_16137613","title":"Anti-citrullinated protein/peptide antibodies (ACPA) in rheumatoid arthritis: specificity and relation with rheumatoid factor.","date":"2005","source":"Autoimmunity reviews","url":"https://pubmed.ncbi.nlm.nih.gov/16137613","citation_count":66,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21741375","id":"PMC_21741375","title":"An essential role for transcription before the MBT in Xenopus laevis.","date":"2011","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/21741375","citation_count":65,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15804701","id":"PMC_15804701","title":"Autoantibodies to citrullinated proteins: ACPA.","date":"2005","source":"Autoimmunity","url":"https://pubmed.ncbi.nlm.nih.gov/15804701","citation_count":63,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9499578","id":"PMC_9499578","title":"Mouse embryos do not wait for the MBT: chromatin and RNA polymerase remodeling in genome activation at the onset of development.","date":"1998","source":"Developmental genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9499578","citation_count":63,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8082300","id":"PMC_8082300","title":"Cytotoxic effects of antibodies to proteinase 3 (C-ANCA) on human endothelial cells.","date":"1994","source":"Clinical and experimental immunology","url":"https://pubmed.ncbi.nlm.nih.gov/8082300","citation_count":63,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21998120","id":"PMC_21998120","title":"The ACPA recognition profile and subgrouping of ACPA-positive RA patients.","date":"2011","source":"Annals of the rheumatic diseases","url":"https://pubmed.ncbi.nlm.nih.gov/21998120","citation_count":61,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29033912","id":"PMC_29033912","title":"The Infectious Basis of ACPA-Positive Rheumatoid Arthritis.","date":"2017","source":"Frontiers in microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/29033912","citation_count":58,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28606964","id":"PMC_28606964","title":"Differences in the symptomatic phase preceding ACPA-positive and ACPA-negative RA: a longitudinal study in arthralgia during progression to clinical arthritis.","date":"2017","source":"Annals of the rheumatic diseases","url":"https://pubmed.ncbi.nlm.nih.gov/28606964","citation_count":57,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34017121","id":"PMC_34017121","title":"Repression of CTSG, ELANE and PRTN3-mediated histone H3 proteolytic cleavage promotes monocyte-to-macrophage differentiation.","date":"2021","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/34017121","citation_count":56,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30662440","id":"PMC_30662440","title":"Differential ACPA Binding to Nuclear Antigens Reveals a PAD-Independent Pathway and a Distinct Subset of Acetylation Cross-Reactive Autoantibodies in Rheumatoid Arthritis.","date":"2019","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/30662440","citation_count":56,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21857667","id":"PMC_21857667","title":"The tumour suppressor L(3)mbt inhibits neuroepithelial proliferation and acts on insulator elements.","date":"2011","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/21857667","citation_count":54,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23737967","id":"PMC_23737967","title":"HLA-DRB1 genotypes and the risk of developing anti citrullinated protein antibody (ACPA) positive rheumatoid arthritis.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23737967","citation_count":51,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8499060","id":"PMC_8499060","title":"Cellular immune responses and pathogenesis in c-ANCA positive vasculitides.","date":"1993","source":"Journal of autoimmunity","url":"https://pubmed.ncbi.nlm.nih.gov/8499060","citation_count":48,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12490550","id":"PMC_12490550","title":"Mbt, a Drosophila PAK protein, combines with Cdc42 to regulate photoreceptor cell morphogenesis.","date":"2003","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/12490550","citation_count":48,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26358872","id":"PMC_26358872","title":"Coordinating Cell Cycle Remodeling with Transcriptional Activation at the Drosophila MBT.","date":"2015","source":"Current topics in developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/26358872","citation_count":46,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33452006","id":"PMC_33452006","title":"Novel autoantibodies identified in ACPA-negative rheumatoid arthritis.","date":"2021","source":"Annals of the rheumatic diseases","url":"https://pubmed.ncbi.nlm.nih.gov/33452006","citation_count":45,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16899453","id":"PMC_16899453","title":"Structure of Francisella tularensis AcpA: prototype of a unique superfamily of acid phosphatases and phospholipases C.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16899453","citation_count":45,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29070529","id":"PMC_29070529","title":"Anticitrullinated protein/peptide antibody multiplexing defines an extended group of ACPA-positive rheumatoid arthritis patients with distinct genetic and environmental determinants.","date":"2017","source":"Annals of the rheumatic diseases","url":"https://pubmed.ncbi.nlm.nih.gov/29070529","citation_count":45,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11160805","id":"PMC_11160805","title":"Identification of the acid phosphatase (acpA) gene homologues in pathogenic and non-pathogenic Burkholderia spp. facilitates TnphoA mutagenesis.","date":"2001","source":"Microbiology (Reading, England)","url":"https://pubmed.ncbi.nlm.nih.gov/11160805","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26617177","id":"PMC_26617177","title":"CCR6(+) Th cell populations distinguish ACPA positive from ACPA negative rheumatoid arthritis.","date":"2015","source":"Arthritis research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/26617177","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32532752","id":"PMC_32532752","title":"Bacterial citrullinated epitopes generated by Porphyromonas gingivalis infection-a missing link for ACPA production.","date":"2020","source":"Annals of the rheumatic diseases","url":"https://pubmed.ncbi.nlm.nih.gov/32532752","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18596726","id":"PMC_18596726","title":"ANCA patients have T cells responsive to complementary PR-3 antigen.","date":"2008","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/18596726","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9510021","id":"PMC_9510021","title":"Pre-MBT patterning of early gene regulation in Xenopus: the role of the cortical rotation and mesoderm induction.","date":"1998","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/9510021","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25997035","id":"PMC_25997035","title":"In antisynthetase syndrome, ACPA are associated with severe and erosive arthritis: an overlapping rheumatoid arthritis and antisynthetase syndrome.","date":"2015","source":"Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/25997035","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29512823","id":"PMC_29512823","title":"Variable domain N-linked glycosylation and negative surface charge are key features of monoclonal ACPA: Implications for B-cell selection.","date":"2018","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/29512823","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31471298","id":"PMC_31471298","title":"On the presence of HLA-SE alleles and ACPA-IgG variable domain glycosylation in the phase preceding the development of rheumatoid arthritis.","date":"2019","source":"Annals of the rheumatic diseases","url":"https://pubmed.ncbi.nlm.nih.gov/31471298","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24333573","id":"PMC_24333573","title":"Differential role of the basolateral amygdala 5-HT3 and 5-HT4 serotonin receptors upon ACPA-induced anxiolytic-like behaviors and emotional memory deficit in mice.","date":"2013","source":"Behavioural brain research","url":"https://pubmed.ncbi.nlm.nih.gov/24333573","citation_count":41,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23958703","id":"PMC_23958703","title":"HLA shared epitope and ACPA: just a marker or an active player?","date":"2013","source":"Autoimmunity reviews","url":"https://pubmed.ncbi.nlm.nih.gov/23958703","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21873494","id":"PMC_21873494","title":"Mutational and phylogenetic analyses of the mycobacterial mbt gene cluster.","date":"2011","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/21873494","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21087494","id":"PMC_21087494","title":"Anticitrullinated protein antibody (ACPA) in rheumatoid arthritis: influence of an interaction between HLA-DRB1 shared epitope and a deletion polymorphism in glutathione S-transferase in a cross-sectional study.","date":"2010","source":"Arthritis research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/21087494","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23463689","id":"PMC_23463689","title":"Low-avidity anticitrullinated protein antibodies (ACPA) are associated with a higher rate of joint destruction in rheumatoid arthritis.","date":"2013","source":"Annals of the rheumatic diseases","url":"https://pubmed.ncbi.nlm.nih.gov/23463689","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36278483","id":"PMC_36278483","title":"Randomized phase I trial of antigen-specific tolerizing immunotherapy with peptide/calcitriol liposomes in ACPA+ rheumatoid arthritis.","date":"2022","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/36278483","citation_count":39,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15889154","id":"PMC_15889154","title":"Impaired maturation of myeloid progenitors in mice lacking novel Polycomb group protein MBT-1.","date":"2005","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/15889154","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23928305","id":"PMC_23928305","title":"The malignant brain tumor (MBT) domain protein SFMBT1 is an integral histone reader subunit of the LSD1 demethylase complex for chromatin association and epithelial-to-mesenchymal transition.","date":"2013","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23928305","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18636970","id":"PMC_18636970","title":"The Drosophila p21-activated kinase Mbt modulates DE-cadherin-mediated cell adhesion by phosphorylation of Armadillo.","date":"2008","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/18636970","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21437264","id":"PMC_21437264","title":"H3K9me2/3 binding of the MBT domain protein LIN-61 is essential for Caenorhabditis elegans vulva development.","date":"2011","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21437264","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23505239","id":"PMC_23505239","title":"Smoking, the HLA-DRB1 shared epitope and ACPA fine-specificity in Koreans with rheumatoid arthritis: evidence for more than one pathogenic pathway linking smoking to disease.","date":"2013","source":"Annals of the rheumatic diseases","url":"https://pubmed.ncbi.nlm.nih.gov/23505239","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26509066","id":"PMC_26509066","title":"ACPA-positive primary Sjögren's syndrome: true primary or rheumatoid arthritis-associated Sjögren's syndrome?","date":"2015","source":"RMD open","url":"https://pubmed.ncbi.nlm.nih.gov/26509066","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20685770","id":"PMC_20685770","title":"Anxiolytic-like effect induced by the cannabinoid CB1 receptor agonist, arachydonilcyclopropylamide (ACPA), in the rat amygdala is mediated through the D1 and D2 dopaminergic systems.","date":"2010","source":"Journal of psychopharmacology (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/20685770","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27474440","id":"PMC_27474440","title":"Loss of l(3)mbt leads to acquisition of the ping-pong cycle in Drosophila ovarian somatic cells.","date":"2016","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/27474440","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33431819","id":"PMC_33431819","title":"ACPA decreases non-small cell lung cancer line growth through Akt/PI3K and JNK pathways in vitro.","date":"2021","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/33431819","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12010574","id":"PMC_12010574","title":"Proteinase-3 as the major autoantigen of c-ANCA is strongly expressed in lung tissue of patients with Wegener's granulomatosis.","date":"2002","source":"Arthritis research","url":"https://pubmed.ncbi.nlm.nih.gov/12010574","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12062936","id":"PMC_12062936","title":"Determination of the sensitising activity of the rubber contact sensitisers TMTD, ZDMC, MBT and DEA in a modified local lymph node assay and the effect of sodium dodecyl sulfate pretreatment on local lymph node responses.","date":"2002","source":"Toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/12062936","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32917833","id":"PMC_32917833","title":"Association between number and type of different ACPA fine specificities with lung abnormalities in early, untreated rheumatoid arthritis.","date":"2020","source":"RMD open","url":"https://pubmed.ncbi.nlm.nih.gov/32917833","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36919771","id":"PMC_36919771","title":"Fusobacterium nucleatum promotes the early occurrence of esophageal cancer through upregulation of IL-32/PRTN3 expression.","date":"2023","source":"Cancer science","url":"https://pubmed.ncbi.nlm.nih.gov/36919771","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33010041","id":"PMC_33010041","title":"Increased expression of CXCL2 in ACPA-positive rheumatoid arthritis and its role in osteoclastogenesis.","date":"2020","source":"Clinical and experimental immunology","url":"https://pubmed.ncbi.nlm.nih.gov/33010041","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30797851","id":"PMC_30797851","title":"Anxiolytic and antidepressant effects of ACPA and harmaline co-treatment.","date":"2019","source":"Behavioural brain research","url":"https://pubmed.ncbi.nlm.nih.gov/30797851","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32940038","id":"PMC_32940038","title":"Highly Sensitive Dual-Mode Optical Thermometry in Double-Perovskite Oxides via Pr3+/Dy3+ Energy Transfer.","date":"2020","source":"Inorganic chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/32940038","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31905316","id":"PMC_31905316","title":"The P. gingivalis Autocitrullinome Is Not a Target for ACPA in Early Rheumatoid Arthritis.","date":"2020","source":"Journal of dental research","url":"https://pubmed.ncbi.nlm.nih.gov/31905316","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36027873","id":"PMC_36027873","title":"ACPA-negative rheumatoid arthritis: From immune mechanisms to clinical translation.","date":"2022","source":"EBioMedicine","url":"https://pubmed.ncbi.nlm.nih.gov/36027873","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31171038","id":"PMC_31171038","title":"Outcome of patients with early arthritis without rheumatoid factor and ACPA and predictors of rheumatoid arthritis in the ESPOIR cohort.","date":"2019","source":"Arthritis research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/31171038","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22570633","id":"PMC_22570633","title":"LINT, a novel dL(3)mbt-containing complex, represses malignant brain tumour signature genes.","date":"2012","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22570633","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10806358","id":"PMC_10806358","title":"Cloning of a novel murine gene Sfmbt, Scm-related gene containing four mbt domains, structurally belonging to the Polycomb group of genes.","date":"2000","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/10806358","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18256536","id":"PMC_18256536","title":"Beyond histone methyl-lysine binding: how malignant brain tumor (MBT) protein L3MBTL1 impacts chromatin structure.","date":"2008","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/18256536","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30007856","id":"PMC_30007856","title":"ACPA mediates the interplay between innate and adaptive immunity in rheumatoid arthritis.","date":"2018","source":"Autoimmunity reviews","url":"https://pubmed.ncbi.nlm.nih.gov/30007856","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24243547","id":"PMC_24243547","title":"Meta-analysis of expression of l(3)mbt tumor-associated germline genes supports the model that a soma-to-germline transition is a hallmark of human cancers.","date":"2013","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/24243547","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16006536","id":"PMC_16006536","title":"Anti-proteinase 3 antibodies (c-ANCA) prime CD14-dependent leukocyte activation.","date":"2005","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/16006536","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33374674","id":"PMC_33374674","title":"Inflammatory Proteins HMGA2 and PRTN3 as Drivers of Vulvar Squamous Cell Carcinoma Progression.","date":"2020","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/33374674","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31644522","id":"PMC_31644522","title":"LTF, PRTN3, and MNDA in Synovial Fluid as Promising Biomarkers for Periprosthetic Joint Infection: Identification by Quadrupole Orbital-Trap Mass Spectrometry.","date":"2019","source":"The Journal of bone and joint surgery. American volume","url":"https://pubmed.ncbi.nlm.nih.gov/31644522","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21339219","id":"PMC_21339219","title":"Genetics of ACPA-positive rheumatoid arthritis: the beginning of the end?","date":"2011","source":"Annals of the rheumatic diseases","url":"https://pubmed.ncbi.nlm.nih.gov/21339219","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16026537","id":"PMC_16026537","title":"Midblastula transition (MBT) of the cell cycles in the yolk and pigment granule-free translucent blastomeres obtained from centrifuged Xenopus embryos.","date":"2005","source":"Development, growth & differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/16026537","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32293530","id":"PMC_32293530","title":"Differential regulation and correlation between galectin-9 and anti-CCP antibody (ACPA) in rheumatoid arthritis patients.","date":"2020","source":"Arthritis research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/32293530","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25927497","id":"PMC_25927497","title":"Anti-citrullinated peptide/protein antibody (ACPA)-negative RA shares a large proportion of susceptibility loci with ACPA-positive RA: a meta-analysis of genome-wide association study in a Japanese population.","date":"2015","source":"Arthritis research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/25927497","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28569212","id":"PMC_28569212","title":"The prevalence of ACPA is lower in rheumatoid arthritis patients with an older age of onset but the composition of the ACPA response appears identical.","date":"2017","source":"Arthritis research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/28569212","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25708319","id":"PMC_25708319","title":"Expression and specificity profile of the major acetate transporter AcpA in Aspergillus nidulans.","date":"2015","source":"Fungal genetics and biology : FG & B","url":"https://pubmed.ncbi.nlm.nih.gov/25708319","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7621597","id":"PMC_7621597","title":"Proteolysis of classic anti-neutrophil cytoplasmic autoantibodies (C-ANCA) by neutrophil proteinase 3.","date":"1995","source":"Clinical and experimental immunology","url":"https://pubmed.ncbi.nlm.nih.gov/7621597","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21732051","id":"PMC_21732051","title":"Anti-citrullinated protein antibodies (ACPA) in early rheumatoid arthritis.","date":"2011","source":"Modern rheumatology","url":"https://pubmed.ncbi.nlm.nih.gov/21732051","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30582233","id":"PMC_30582233","title":"MicroRNA miR-252 targets mbt to control the developmental growth of Drosophila.","date":"2019","source":"Insect molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/30582233","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22129077","id":"PMC_22129077","title":"The fine specificity of IgM anti-citrullinated protein antibodies (ACPA) is different from that of IgG ACPA.","date":"2011","source":"Arthritis research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/22129077","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28882619","id":"PMC_28882619","title":"Variable domain glycosylation of ACPA-IgG: A missing link in the maturation of the ACPA response?","date":"2017","source":"Clinical immunology (Orlando, Fla.)","url":"https://pubmed.ncbi.nlm.nih.gov/28882619","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29507112","id":"PMC_29507112","title":"Rap1, Canoe and Mbt cooperate with Bazooka to promote zonula adherens assembly in the fly photoreceptor.","date":"2018","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/29507112","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31366403","id":"PMC_31366403","title":"Rheumatoid arthritis-relevant DNA methylation changes identified in ACPA-positive asymptomatic individuals using methylome capture sequencing.","date":"2019","source":"Clinical epigenetics","url":"https://pubmed.ncbi.nlm.nih.gov/31366403","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33170478","id":"PMC_33170478","title":"Distinctive Clinical Characteristics and Outcome of ILD-Onset Rheumatoid Arthritis and ACPA-Positive ILD: a Longitudinal Cohort of 282 Cases.","date":"2020","source":"Clinical reviews in allergy & immunology","url":"https://pubmed.ncbi.nlm.nih.gov/33170478","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32107036","id":"PMC_32107036","title":"Circulating IFN-γ producing CD4+ T cells and IL-17A producing CD4+ T cells, HLA-shared epitope and ACPA may characterize the clinical response to therapy in rheumatoid arthritis patients.","date":"2020","source":"Human immunology","url":"https://pubmed.ncbi.nlm.nih.gov/32107036","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29290168","id":"PMC_29290168","title":"The Economic Burden of ACPA-Positive Status Among Patients with Rheumatoid Arthritis.","date":"2017","source":"Journal of managed care & specialty pharmacy","url":"https://pubmed.ncbi.nlm.nih.gov/29290168","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23505385","id":"PMC_23505385","title":"A role for the malignant brain tumour (MBT) domain protein LIN-61 in DNA double-strand break repair by homologous recombination.","date":"2013","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23505385","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23385818","id":"PMC_23385818","title":"Regulation of DU145 prostate cancer cell growth by Scm-like with four mbt domains 2.","date":"2013","source":"Journal of biosciences","url":"https://pubmed.ncbi.nlm.nih.gov/23385818","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29128791","id":"PMC_29128791","title":"ACPA and JWH-133 modulate the vascular tone of superior mesenteric arteries through cannabinoid receptors, BKCa channels, and nitric oxide dependent mechanisms.","date":"2017","source":"Pharmacological reports : PR","url":"https://pubmed.ncbi.nlm.nih.gov/29128791","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26464456","id":"PMC_26464456","title":"The involvement of medial septum 5-HT1 and 5-HT2 receptors on ACPA-induced memory consolidation deficit: possible role of TRPC3, TRPC6 and TRPV2.","date":"2015","source":"Journal of psychopharmacology (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/26464456","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10583443","id":"PMC_10583443","title":"Anti-PR-3 antibodies induce endothelial IL-8 release.","date":"1999","source":"European journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/10583443","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31446118","id":"PMC_31446118","title":"Detection of anti-citrullinated protein antibody (ACPA) in saliva for rheumatoid arthritis using DBA mice infected with Porphyromonas gingivalis.","date":"2019","source":"Archives of oral biology","url":"https://pubmed.ncbi.nlm.nih.gov/31446118","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31715133","id":"PMC_31715133","title":"Synergistic but not additive effect between ACPA and lithium in the dorsal hippocampal region on spatial learning and memory in rats: Isobolographic analyses.","date":"2019","source":"Chemico-biological interactions","url":"https://pubmed.ncbi.nlm.nih.gov/31715133","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34926155","id":"PMC_34926155","title":"Anti-cyclic citrullinated peptide antibody (ACPA) and Rheumatoid arthritis: Clinical relevance.","date":"2021","source":"Journal of clinical orthopaedics and trauma","url":"https://pubmed.ncbi.nlm.nih.gov/34926155","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29511022","id":"PMC_29511022","title":"L(3)mbt and the LINT complex safeguard cellular identity in the Drosophila ovary.","date":"2018","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/29511022","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25249635","id":"PMC_25249635","title":"Chromatin reader L(3)mbt requires the Myb-MuvB/DREAM transcriptional regulatory complex for chromosomal recruitment.","date":"2014","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/25249635","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27340776","id":"PMC_27340776","title":"SFMBT2 (Scm-like with four mbt domains 2) negatively regulates cell migration and invasion in prostate cancer cells.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/27340776","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27651922","id":"PMC_27651922","title":"Association between RANK, RANKL and OPG polymorphisms with ACPA and erosions in rheumatoid arthritis: results from a meta-analysis involving three French cohorts.","date":"2016","source":"RMD open","url":"https://pubmed.ncbi.nlm.nih.gov/27651922","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35967336","id":"PMC_35967336","title":"Evaluation of the immune feature of ACPA-negative rheumatoid arthritis and the clinical value of matrix metalloproteinase-3.","date":"2022","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/35967336","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37005480","id":"PMC_37005480","title":"Patients with ACPA-positive and ACPA-negative rheumatoid arthritis show different serological autoantibody repertoires and autoantibody associations with disease activity.","date":"2023","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/37005480","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9925946","id":"PMC_9925946","title":"Characterization and localization of the genes for mouse proteinase-3 (Prtn3) and neutrophil elastase (Ela2).","date":"1998","source":"Cytogenetics and cell genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9925946","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33547063","id":"PMC_33547063","title":"Tenosynovitis has a high sensitivity for early ACPA-positive and ACPA-negative RA: a large cross-sectional MRI study.","date":"2021","source":"Annals of the rheumatic diseases","url":"https://pubmed.ncbi.nlm.nih.gov/33547063","citation_count":13,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11389039","id":"PMC_11389039","title":"Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3.","date":"2001","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/11389039","citation_count":672,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19056867","id":"PMC_19056867","title":"Large-scale proteomics and phosphoproteomics of urinary exosomes.","date":"2008","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/19056867","citation_count":607,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"1688612","id":"PMC_1688612","title":"Anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis recognize an elastinolytic enzyme.","date":"1990","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/1688612","citation_count":424,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"2679910","id":"PMC_2679910","title":"Wegener's granulomatosis autoantigen is a novel neutrophil serine proteinase.","date":"1989","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/2679910","citation_count":387,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"2598267","id":"PMC_2598267","title":"Down-regulation of a serine protease, myeloblastin, causes growth arrest and differentiation of promyelocytic leukemia cells.","date":"1989","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/2598267","citation_count":294,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10339575","id":"PMC_10339575","title":"Converting enzyme-independent release of tumor necrosis factor alpha and IL-1beta from a stimulated human monocytic cell line in the presence of activated neutrophils or purified proteinase 3.","date":"1999","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/10339575","citation_count":278,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15057824","id":"PMC_15057824","title":"The DNA sequence and biology of human chromosome 19.","date":"2004","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/15057824","citation_count":271,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"2501794","id":"PMC_2501794","title":"Antibiotic proteins of human polymorphonuclear leukocytes.","date":"1989","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/2501794","citation_count":257,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"2033050","id":"PMC_2033050","title":"Characterization of proteinase-3 (PR-3), a neutrophil serine proteinase. Structural and functional properties.","date":"1991","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/2033050","citation_count":255,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"2377228","id":"PMC_2377228","title":"Wegener's autoantigen decoded.","date":"1990","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/2377228","citation_count":242,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11714826","id":"PMC_11714826","title":"Neutrophil proteinase 3-mediated induction of bioactive IL-18 secretion by human oral epithelial cells.","date":"2001","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/11714826","citation_count":232,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20551380","id":"PMC_20551380","title":"Proteomics characterization of extracellular space components in the human aorta.","date":"2010","source":"Molecular & cellular proteomics : MCP","url":"https://pubmed.ncbi.nlm.nih.gov/20551380","citation_count":231,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12200377","id":"PMC_12200377","title":"CD8 T-cell responses to Wilms tumor gene product WT1 and proteinase 3 in patients with acute myeloid leukemia.","date":"2002","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/12200377","citation_count":219,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25092677","id":"PMC_25092677","title":"Increased neutrophil elastase and proteinase 3 and augmented NETosis are closely associated with β-cell autoimmunity in patients with type 1 diabetes.","date":"2014","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/25092677","citation_count":167,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19913121","id":"PMC_19913121","title":"Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip.","date":"2009","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19913121","citation_count":164,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"2258701","id":"PMC_2258701","title":"Cloning of cDNA for proteinase 3: a serine protease, antibiotic, and autoantigen from human neutrophils.","date":"1990","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/2258701","citation_count":160,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10498622","id":"PMC_10498622","title":"Presence of proteinase 3 in secretory vesicles: evidence of a novel, highly mobilizable intracellular pool distinct from azurophil granules.","date":"1999","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/10498622","citation_count":145,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23533145","id":"PMC_23533145","title":"In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.","date":"2013","source":"Proteomics","url":"https://pubmed.ncbi.nlm.nih.gov/23533145","citation_count":138,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28029757","id":"PMC_28029757","title":"Identification of Functional and Expression Polymorphisms Associated With Risk for Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis.","date":"2017","source":"Arthritis & rheumatology (Hoboken, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/28029757","citation_count":138,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12191967","id":"PMC_12191967","title":"Neutrophil membrane expression of proteinase 3 (PR3) is related to relapse in PR3-ANCA-associated vasculitis.","date":"2002","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/12191967","citation_count":137,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"1518849","id":"PMC_1518849","title":"Three human elastase-like genes coordinately expressed in the myelomonocyte lineage are organized as a single genetic locus on 19pter.","date":"1992","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/1518849","citation_count":136,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8757293","id":"PMC_8757293","title":"The crystal structure of PR3, a neutrophil serine proteinase antigen of Wegener's granulomatosis antibodies.","date":"1996","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/8757293","citation_count":133,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16488976","id":"PMC_16488976","title":"Proteinase 3 is an IL-32 binding protein.","date":"2006","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/16488976","citation_count":124,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12506139","id":"PMC_12506139","title":"Membrane expression of proteinase 3 is genetically determined.","date":"2003","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/12506139","citation_count":122,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"30692621","id":"PMC_30692621","title":"SERPINB1-mediated checkpoint of inflammatory caspase activation.","date":"2019","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/30692621","citation_count":118,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12393722","id":"PMC_12393722","title":"Interferon-alpha, but not the ABL-kinase inhibitor imatinib (STI571), induces expression of myeloblastin and a specific T-cell response in chronic myeloid leukemia.","date":"2002","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/12393722","citation_count":115,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":52094,"output_tokens":2671,"usd":0.098173},"stage2":{"model":"claude-opus-4-6","input_tokens":6002,"output_tokens":2425,"usd":0.135953},"total_usd":0.588263,"stage1_batch_id":"msgbatch_01SUR8NDzVrNmyszWyJeCct7","stage2_batch_id":"msgbatch_01G7Yfutko3cDWzejrwH5AMx","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":66381,"output_tokens":6785,"usd":0.150459},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":10657,"output_tokens":3300,"usd":0.203678}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2021,\n      \"finding\": \"PRTN3 (proteinase 3) catalyzes proteolytic cleavage of histone H3 at the amino terminus (H3ΔN) in human peripheral blood monocytes. This histone H3 cleavage mark is abundant in monocytes and becomes undetectable as monocytes differentiate into macrophages. Simultaneous depletion of PRTN3 together with cathepsin G and neutrophil elastase results in loss of H3ΔN and increased chromatin accessibility, priming chromatin for gene expression reprogramming during monocyte-to-macrophage differentiation.\",\n      \"method\": \"siRNA-mediated simultaneous depletion of NSPs (PRTN3, CTSG, ELANE) in monocytic cells; integrative epigenomic analysis (ChIP-seq, ATAC-seq); primary monocyte/macrophage fractionation; mass spectrometry identification of H3ΔN\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods (loss-of-function, epigenomic profiling, MS), direct enzymatic activity established with specific cellular phenotype\",\n      \"pmids\": [\"34017121\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"C-ANCA (anti-PR3 antibodies) inhibit the complexation of proteinase 3 (PR3) with its major physiological inhibitor alpha-1-antitrypsin (alpha1AT), and this inhibitory activity correlates with disease activity in Wegener's granulomatosis, demonstrating a functional interaction between PR3 and alpha1AT that is disrupted by ANCA.\",\n      \"method\": \"In vitro PR3-alpha1AT complexation assays with patient sera; correlation with disease activity scores; serial serum sampling from WG relapse patients\",\n      \"journal\": \"Clinical and experimental immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct biochemical assay of PR3-inhibitor interaction, replicated across multiple patients and time points in a single study\",\n      \"pmids\": [\"8370167\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"PR3 translocates to the membrane of TNF-alpha-activated human endothelial cells, and antibodies to PR3 mediate complement-independent cytotoxicity against endothelial cells via antibody-dependent cellular cytotoxicity (ADCC) requiring both surface PR3 expression and cytokine-primed neutrophils.\",\n      \"method\": \"Chromium-51 release cytotoxicity assay; inhibition experiments with purified antigen; co-cultivation of primed neutrophils with endothelial cells\",\n      \"journal\": \"Clinical and experimental immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct functional assay with specific inhibition controls establishing PR3 surface localization and ADCC mechanism\",\n      \"pmids\": [\"8082300\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"Proteinase 3 (PR3) cleaves human IgG, including C-ANCA IgG complexed to PR3; all IgG subclass proteins are susceptible, and inhibiting C-ANCA IgG bound to PR3 are proteolyzed into small peptides, demonstrating PR3 protease activity toward immunoglobulins.\",\n      \"method\": \"In vitro proteolysis assay with purified PR3 and human IgG subclass proteins; comparison with neutrophil elastase cleavage products; gel electrophoresis of digestion products\",\n      \"journal\": \"Clinical and experimental immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — direct in vitro enzymatic assay demonstrating IgG as a substrate of PR3\",\n      \"pmids\": [\"7621597\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Anti-PR3 antibodies induce IL-8 synthesis in TNF-alpha/IL-1beta-primed human endothelial cells through activation of NF-kappaB; this effect requires cytokine-induced surface expression of PR3 on endothelial cells and is dependent on de novo protein synthesis.\",\n      \"method\": \"RT-PCR for IL-8 mRNA; ELISA for IL-8 protein; Western blot of NF-kappaB p65 in nuclear extracts; cycloheximide inhibition; monoclonal anti-PR3 antibody (WGM2) as control\",\n      \"journal\": \"European journal of clinical investigation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — mechanistic pathway (PR3→anti-PR3→NF-kappaB→IL-8) established with multiple assays and specific inhibition controls in a single study\",\n      \"pmids\": [\"10583443\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"PR3 is expressed in normal human lung tissue and is upregulated in lung tissue of patients with Wegener's granulomatosis; expression is localized predominantly in parenchymal cells (pneumocytes type I and II) and macrophages rather than neutrophils.\",\n      \"method\": \"Immunohistochemistry of lung tissue biopsies from WG patients and controls; localization of PR3 to specific cell types\",\n      \"journal\": \"Arthritis research\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — direct localization by IHC, single study, no functional consequence experimentally tested\",\n      \"pmids\": [\"12010574\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Anti-PR3 antibodies (C-ANCA) prime CD14-dependent monocyte and neutrophil activation: pre-incubation with anti-PR3 antibodies markedly enhances IL-8, TNF-alpha, and IL-6 release upon subsequent LPS or LTA challenge, and this priming involves upregulation of membrane CD14 expression.\",\n      \"method\": \"In vitro monocyte/neutrophil stimulation assays; ELISA for cytokines; flow cytometry for CD14 expression; comparison with WG patient-derived ANCA-IgG versus normal IgG\",\n      \"journal\": \"Journal of leukocyte biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — mechanistic pathway (anti-PR3 → CD14 upregulation → enhanced LPS/LTA response) established with multiple cytokine readouts and flow cytometry, replicated with patient-derived antibodies\",\n      \"pmids\": [\"16006536\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Patients with PR3-ANCA also harbor CD4+ Th1 memory T cells responsive to complementary-PR3 (cPR3), a protein encoded by the antisense RNA of the PR3 gene; cPR3-responsive T cells proliferate and secrete IFN-gamma in response to cPR3(138-169) peptide, and HLA-DRB1*15 is predicted to bind this peptide with high affinity.\",\n      \"method\": \"T cell proliferation assays; IFN-gamma secretion assays; selective culture conditions for memory vs naïve T cells; scrambled peptide controls; comparison with MPO-ANCA patients\",\n      \"journal\": \"Kidney international\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct functional T cell response to cPR3 demonstrated with multiple readouts and specificity controls\",\n      \"pmids\": [\"18596726\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"The mouse Prtn3 gene consists of five exons and four introns (approximately 3.7 kb), is located on mouse chromosome 10C2 within 2.2 kb of the neutrophil elastase gene (Ela2), and the proximal promoter contains a TATA box, c-myb and ets transcriptional sites; the catalytic triad is conserved between mouse and human PR3.\",\n      \"method\": \"cDNA cloning and sequencing; FISH chromosomal localization; promoter sequence analysis; sequence alignment with human PR3\",\n      \"journal\": \"Cytogenetics and cell genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct gene characterization establishing genomic structure, chromosomal location, and conservation of catalytic residues\",\n      \"pmids\": [\"9925946\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Fusobacterium nucleatum promotes proliferation of esophageal squamous cell carcinoma cells by upregulating IL-32/PRTN3 expression and thereby activating the PI3K/AKT signaling pathway.\",\n      \"method\": \"In vitro and in vivo ESCC proliferation assays; RT-PCR and protein expression analysis; pathway inhibition experiments; FISH for Fn detection in tumor tissue\",\n      \"journal\": \"Cancer science\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single study, pathway placement based on correlation of PRTN3 upregulation with PI3K/AKT activation without direct mechanistic reconstitution of PRTN3's role\",\n      \"pmids\": [\"36919771\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"PRTN3 encodes proteinase 3 (PR3), a neutrophil serine protease stored in azurophil granules that: (1) directly catalyzes histone H3 amino-terminal proteolytic cleavage (H3ΔN) in monocytes to regulate chromatin accessibility during monocyte-to-macrophage differentiation; (2) degrades extracellular substrates including elastin and cleaves IgG; (3) is inhibited by alpha-1-antitrypsin, and anti-PR3 autoantibodies (C-ANCA) block this inhibitor complexation and prime CD14-dependent leukocyte activation via NF-kappaB-dependent IL-8 production; and (4) can translocate to the surface of cytokine-activated endothelial cells where anti-PR3 antibodies mediate ADCC-dependent cytotoxicity.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1989,\n      \"finding\": \"PRTN3 (proteinase 3/myeloblastin) was identified as a novel neutrophil serine proteinase and the target autoantigen of c-ANCA autoantibodies in Wegener's granulomatosis. The 29-kDa protein was purified from neutrophils, showed a novel N-terminal sequence homologous to serine proteinases, and bound radiolabeled diisopropyl fluorophosphate, confirming serine protease activity.\",\n      \"method\": \"Affinity purification, Western blot, monoclonal antibody generation, N-terminal sequencing, DFP binding assay\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro enzymatic characterization, multiple orthogonal methods, foundational discovery replicated across labs\",\n      \"pmids\": [\"2679910\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1989,\n      \"finding\": \"PRTN3 (myeloblastin) expression is down-regulated during induced differentiation of HL-60 promyelocytic leukemia cells, and antisense oligodeoxynucleotide-mediated inhibition of myeloblastin expression inhibits proliferation and induces differentiation, demonstrating a functional role for PRTN3 in maintaining the proliferative state of myeloid progenitor cells.\",\n      \"method\": \"Antisense oligodeoxynucleotide knockdown, flow cytometry, Northern blot, cell proliferation assays\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — functional loss-of-function with defined cellular phenotype (growth arrest and differentiation), replicated with multiple inducers\",\n      \"pmids\": [\"2598267\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1990,\n      \"finding\": \"PRTN3 cDNA was cloned from human bone marrow, revealing a primary structure with high homology to elastase, cathepsin G, and other serine proteases. The protein contains the catalytic triad and elastase-like substrate binding pocket, is more abundant in neutrophils than elastase, and has a similar proteolytic profile. It is encoded by a single gene.\",\n      \"method\": \"cDNA cloning, N-terminal sequencing, CNBr fragment sequencing, Southern blot\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — definitive structural/sequence characterization with functional validation\",\n      \"pmids\": [\"2258701\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1990,\n      \"finding\": \"The autoantigen of anti-neutrophil cytoplasm antibodies (ANCA) in Wegener's granulomatosis was identified as proteinase 3, an elastinolytic neutral serine proteinase isolated by affinity chromatography from degranulated neutrophils, with 17 NH2-terminal amino acids showing homology to serine proteinases.\",\n      \"method\": \"Affinity chromatography, phorbol ester-induced neutrophil degranulation, N-terminal sequence analysis, elastinolytic activity assay\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — biochemical purification and enzymatic characterization, foundational paper (424 citations)\",\n      \"pmids\": [\"1688612\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1990,\n      \"finding\": \"The Wegener's granulomatosis autoantigen was decoded as proteinase 3, a member of the serine proteinase family.\",\n      \"method\": \"Biochemical characterization, sequence analysis\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — foundational identification, highly cited\",\n      \"pmids\": [\"2377228\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1991,\n      \"finding\": \"PRTN3 was biochemically characterized as a serine proteinase with elastase-like specificity (preference for small aliphatic amino acids at P1 site: alanine, serine, valine). It degrades extracellular matrix proteins including fibronectin, laminin, vitronectin, and collagen type IV but not interstitial collagens I and III. It is inhibited by alpha1-proteinase inhibitor and alpha2-macroglobulin but NOT by secretory leukoprotease inhibitor or alpha1-antichymotrypsin, distinguishing it from elastase and cathepsin G.\",\n      \"method\": \"In vitro enzymatic assays with chromogenic substrates and matrix proteins, inhibitor profiling, peptide substrate analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — detailed in vitro reconstitution with multiple substrates, rigorous inhibitor profiling\",\n      \"pmids\": [\"2033050\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"The genes for PRTN3 (PR3), neutrophil elastase (NE), and azurocidin (AZU) are organized as a single genetic locus on chromosome 19pter, with PR3 separated by 8 kb from AZU and 3 kb from NE. All three genes are coordinately down-regulated during terminal differentiation of the premonocytic cell line U937, and share the same five-exon structure typical of granule-associated serine proteases.\",\n      \"method\": \"Cosmid cloning, FISH, physical mapping, exon-intron analysis, Northern blot during differentiation\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — definitive genomic organization with functional validation of coordinate expression\",\n      \"pmids\": [\"1518849\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"C-ANCA (anti-PR3 antibodies) interfere with PR3 proteolytic activity and inhibit complexation of PR3 with its major physiologic inhibitor alpha1-antitrypsin (alpha1-AT). The degree of C-ANCA inhibition of PR3-alpha1-AT complexation correlates with disease activity in Wegener's granulomatosis, whereas C-ANCA titer alone does not.\",\n      \"method\": \"Serial serum sample analysis, PR3-alpha1-AT complexation assay, disease activity scoring, correlation analysis\",\n      \"journal\": \"Clinical and experimental immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional inhibition assay with clinical correlation; single lab\",\n      \"pmids\": [\"8370167\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"Anti-PR3 antibodies (C-ANCA) recognize PR3 translocated to the membrane of TNF-alpha-treated human endothelial cells and mediate cytotoxicity against those cells in a complement-independent manner requiring co-cultivation with cytokine-primed neutrophils. Cytotoxicity was measured by Cr-release assay and was inhibited by preincubation with purified PR3 antigen.\",\n      \"method\": \"Chromium release cytotoxicity assay, affinity-purified antibodies, TNF-alpha priming of endothelial cells, neutrophil co-culture\",\n      \"journal\": \"Clinical and experimental immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional cellular assay with defined mechanistic controls; single lab\",\n      \"pmids\": [\"8082300\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"PR3 enzymatically cleaves human IgG of all subclasses, including C-ANCA IgG complexed to the enzyme. Cleavage products differ from those generated by neutrophil elastase, demonstrating a distinct proteolytic specificity of PR3 toward immunoglobulins.\",\n      \"method\": \"In vitro proteolysis assay, gel electrophoresis analysis of cleavage products, comparison with human neutrophil elastase\",\n      \"journal\": \"Clinical and experimental immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — in vitro enzymatic assay; single lab, moderate follow-up\",\n      \"pmids\": [\"7621597\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"The crystal structure of PR3 was solved at 2.2 Å resolution by molecular replacement. The overall fold consists of two beta-barrel domains typical of the chymotrypsin family. The substrate binding site S1 pocket is defined by a Val-to-Ile substitution at position 190 (explaining preference for small aliphatic P1 residues) and Ala-to-Asp substitution at position 213. An N-linked disaccharide is attached to Asn159. Linear antigenic sites reactive with Wegener's granulomatosis autoantibodies map to surface-accessible regions, implicating the pro-form in pathogenesis.\",\n      \"method\": \"X-ray crystallography at 2.2 Å, molecular replacement, structural refinement (R=0.201)\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure with functional residue interpretation, highly cited foundational structure\",\n      \"pmids\": [\"8757293\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"The mouse Prtn3 gene was characterized and mapped by FISH to chromosome 10C2, in close proximity to the neutrophil elastase gene (Ela2). The gene consists of five exons and four introns, conserving the typical granule-associated serine protease structure. The proximal promoter contains a TATA box, c-myb, and ets transcriptional sites. Mouse and human PR3 cDNA share 73% homology (60% at amino acid level); the catalytic triad and placement are conserved.\",\n      \"method\": \"FISH analysis, gene structure characterization, promoter analysis, cDNA sequence comparison\",\n      \"journal\": \"Cytogenetics and cell genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — definitive genomic localization and structural characterization; single study\",\n      \"pmids\": [\"9925946\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"PR3 is present not only in azurophil granules but also in specific granules and in secretory vesicles (the most readily mobilizable intracellular pool), distinct from elastase and myeloperoxidase which are exclusively in azurophil granules. Upon FMLP stimulation, membrane PR3 expression increases in a sequential manner: secretory vesicles first, followed by specific granules, then azurophil granules. Membrane association of PR3 appears covalent (not ionic).\",\n      \"method\": \"Subcellular fractionation, immunoelectron microscopy, FACS analysis of membrane PR3 after FMLP stimulation, comparison with elastase and myeloperoxidase\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal localization methods (fractionation + EM + flow cytometry) with functional mobilization data\",\n      \"pmids\": [\"10498622\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"PR3 induces IL-8 production in TNF-alpha/IL-1beta-activated endothelial cells through activation of NF-kappaB. Anti-PR3 antibodies acting on membrane-expressed PR3 amplify this response. NF-kappaB activation was confirmed by PAGE of nuclear extracts and Western blot for p65.\",\n      \"method\": \"RT-PCR, ELISA, NF-kappaB activation assay, cycloheximide inhibition, monoclonal anti-PR3 antibody (WGM2)\",\n      \"journal\": \"European journal of clinical investigation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — mechanistic signaling pathway identified with multiple methods; single lab\",\n      \"pmids\": [\"10583443\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Purified PR3 (but not neutrophil elastase or cathepsin G) is responsible for converting enzyme-independent release of bioactive TNF-alpha and IL-1beta from LPS-stimulated monocytic cells (THP-1). This was demonstrated using specific inhibitors and purified enzymes, identifying an alternative cytokine processing pathway in local inflammatory contexts.\",\n      \"method\": \"Neutrophil-monocyte co-culture, specific serine protease inhibitors, purified enzymes (PR3, NE, Cat G), ELISA for TNF-alpha and IL-1beta\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted with purified enzyme plus specific inhibitor controls, replicated with multiple approaches\",\n      \"pmids\": [\"10339575\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Proteinase 3 is solely responsible for cleavage of the human cathelicidin hCAP-18 to generate the active antimicrobial peptide LL-37 after neutrophil exocytosis. Immunoelectron microscopy showed both hCAP-18 and azurophil granule proteins in phagolysosomes. Cleavage of hCAP-18 to LL-37 occurred only in exocytosed material, not after phagocytosis.\",\n      \"method\": \"Immunoelectron microscopy, immunoblotting, comparison of NE/PR3/cathepsin G with purified enzymes, subcellular fractionation\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — definitive assignment of enzymatic cleavage role with purified enzymes and multiple orthogonal methods\",\n      \"pmids\": [\"11389039\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Neutrophil proteinase 3 (PR3) induces secretion of bioactive IL-18 (active 18-kDa form) from human oral epithelial cells via a caspase-1-independent pathway, following IFN-gamma priming plus LPS co-stimulation. PR3 was detected only in membrane fractions (not cytoplasm) of treated cells, and induction was blocked by serine proteinase inhibitors but not caspase-1 inhibitors.\",\n      \"method\": \"Cell stimulation assays, Western blot for IL-18 isoforms, caspase-1 inhibitor controls, serine proteinase inhibitors, subcellular fractionation, RT-PCR, IFN-gamma bioassay\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mechanistic identification of caspase-1-independent IL-18 processing pathway with rigorous controls\",\n      \"pmids\": [\"11714826\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Proteinase 3 is strongly expressed in lung parenchymal cells (type I and II pneumocytes) and macrophages in Wegener's granulomatosis tissue, as well as in normal lung tissue (though up-regulated in WG). This non-neutrophil expression pattern suggests these cells may contribute to lung damage via direct interaction with ANCA.\",\n      \"method\": \"Immunohistochemistry of lung biopsies from WG patients and normal tissue\",\n      \"journal\": \"Arthritis research\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — localization by IHC without direct functional consequence established\",\n      \"pmids\": [\"12010574\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Neutrophil membrane expression of PR3 (mPR3) is related to relapse in PR3-ANCA-associated vasculitis. An elevated percentage and level of mPR3 expression on resting neutrophils of WG patients significantly associated with increased relapse risk and relapse rate, but not with disease extent or particular manifestations.\",\n      \"method\": \"FACS analysis of membrane PR3 in 89 WG patients and 72 healthy controls, clinical follow-up analysis\",\n      \"journal\": \"Journal of the American Society of Nephrology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — defined cellular phenotype (membrane localization) linked to clinical outcome in sizable cohort\",\n      \"pmids\": [\"12191967\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Neutrophil membrane PR3 (mPR3) expression is genetically determined. Twin studies demonstrated near-perfect concordance of mPR3 expression in monozygotic twins (r=0.99) versus dizygotic twins (r=0.06). Critically, mPR3 expression is independent of intracellular PR3 content, indicating that membrane targeting rather than total protein level is under genetic control.\",\n      \"method\": \"FACS analysis, monozygotic vs. dizygotic twin study (27 pairs), intracellular flow cytometry, Western blotting, FACSort-separated subpopulation analysis\",\n      \"journal\": \"Journal of the American Society of Nephrology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — elegant twin study design with orthogonal intracellular measurements, strong genetic evidence\",\n      \"pmids\": [\"12506139\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Anti-PR3 antibodies (C-ANCA) prime monocytes and neutrophils for enhanced CD14-dependent activation, resulting in markedly augmented IL-8, TNF-alpha, and IL-6 release upon subsequent LPS or LTA (but not TNF-alpha) challenge. Priming was associated with increased CD14 membrane expression and required 2-6 hours of anti-PR3 pre-incubation.\",\n      \"method\": \"In vitro monocyte/neutrophil stimulation, ELISA for cytokines, flow cytometric analysis of CD14 expression, isotype-matched IgG controls, ANCA-IgG from WG serum\",\n      \"journal\": \"Journal of leukocyte biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — mechanistic cellular pathway identified with multiple cytokine readouts and CD14 expression data; single lab\",\n      \"pmids\": [\"16006536\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Proteinase 3 (PR3) was identified as a specific binding protein for the proinflammatory cytokine IL-32alpha, with dissociation constants of 2.65 nM (urinary PR3) and 1.2 nM (neutrophil-derived PR3) determined by surface plasmon resonance. Irreversible inactivation of PR3 enzymatic activity did not significantly change IL-32 binding, establishing a non-catalytic binding function. However, limited cleavage of IL-32alpha by PR3 enhanced its cytokine activity (MIP-2 and IL-8 induction) more than intact IL-32alpha.\",\n      \"method\": \"IL-32alpha affinity chromatography, mass spectrometry identification, N-terminal microsequencing, surface plasmon resonance, enzymatic inactivation, cytokine induction assays in mouse macrophages and human PBMCs\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — biochemical binding characterized by SPR, enzymatic activity separately assessed, functional consequences demonstrated with reconstituted system\",\n      \"pmids\": [\"16488976\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"ANCA patients with PR3-ANCA have CD4+ TH1 memory T cells responsive to the complementary-PR3 (cPR3) protein encoded by the antisense strand of the PR3 gene. Approximately half of PR3-ANCA patients had cPR3(138-169)-peptide-reactive T cells, whereas MPO-ANCA patients did not, indicating specificity. The HLA-DRB1*15 allele was overrepresented and predicted to bind cPR3(138-169) with high affinity.\",\n      \"method\": \"Memory T cell cultivation, proliferation assays, IFN-gamma secretion assays, HLA-DRB1 typing, peptide binding prediction\",\n      \"journal\": \"Kidney international\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional T cell responses characterized with specificity controls; supports complementary protein autoimmunity model\",\n      \"pmids\": [\"18596726\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"A genome-wide association study identified a functional variant at the PRTN3 locus in which the top-scoring SNP correlated with increased PRTN3 expression in neutrophils, contributing to susceptibility to ANCA-associated vasculitis (granulomatosis with polyangiitis). The overall population attributable fraction for identified variants including PRTN3, HLA-DPB1, SERPINA1, and PTPN22 was 77%.\",\n      \"method\": \"GWAS in 1,986 AAV cases and 4,723 controls, functional annotation, eQTL analysis of neutrophil gene expression\",\n      \"journal\": \"Arthritis & rheumatology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — eQTL analysis linking genetic variant to PRTN3 expression in primary neutrophils; large well-powered study\",\n      \"pmids\": [\"28029757\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"SERPINB1 limits the activity of neutrophil serine proteases (including PR3) through its reactive center loop and separately constrains inflammatory caspase (caspase-1/-4/-5/-11) activation through a C-terminal CARD-binding motif. Knockdown or deletion of SERPINB1 caused spontaneous caspase-1/-4/-5/-11 activation, IL-1β release, and pyroptosis, establishing SERPINB1 as a checkpoint for both PR3 activity and inflammatory caspase activation through genetically and functionally separable mechanisms.\",\n      \"method\": \"SERPINB1 knockout mice, siRNA knockdown, IL-1β ELISA, pyroptosis assays, domain mutagenesis, in vitro protease activity assays\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — genetic knockout combined with domain mutagenesis and functional assays; rigorous mechanistic dissection\",\n      \"pmids\": [\"30692621\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"PRTN3 (proteinase 3), along with cathepsin G and neutrophil elastase, catalyzes proteolytic cleavage of the histone H3 amino terminus (H3ΔN) in human peripheral blood monocytes. This histone mark is repressed as monocytes differentiate into macrophages. Simultaneous NSP depletion in monocytic cells causes H3ΔN loss and increased chromatin accessibility, priming chromatin for gene expression reprogramming during monocyte-to-macrophage differentiation. H3ΔN is enriched at permissive chromatin and actively transcribed genes.\",\n      \"method\": \"NSP depletion, integrative epigenomic analysis (ChIP-seq, ATAC-seq), primary monocyte/macrophage differentiation, patient monocytes from systemic JIA, quantitative histone cleavage assays\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mechanistic epigenomic study with NSP depletion, multiple genome-wide assays, and disease-relevant patient samples\",\n      \"pmids\": [\"34017121\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Fusobacterium nucleatum promotes esophageal squamous cell carcinoma proliferation by upregulating expression of IL-32 and PRTN3, subsequently activating the PI3K/AKT signaling pathway. This was demonstrated in vitro and in vivo.\",\n      \"method\": \"In vitro proliferation assays, in vivo tumor models, FISH, RT-PCR, pathway analysis\",\n      \"journal\": \"Cancer science\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — PRTN3 upregulation identified but direct mechanistic role of PRTN3 protein in PI3K/AKT activation not established by direct biochemical experiment\",\n      \"pmids\": [\"36919771\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"PRTN3 encodes proteinase 3 (PR3/myeloblastin), a neutrophil serine proteinase stored primarily in azurophil granules (and also in secretory vesicles, a highly mobilizable pool) that degrades extracellular matrix proteins with elastase-like specificity (preference for small aliphatic P1 residues), is inhibited by alpha1-antitrypsin and alpha2-macroglobulin but not SLPI, cleaves hCAP-18 to generate the antimicrobial peptide LL-37, processes TNF-alpha and IL-1beta via a converting enzyme-independent pathway, binds IL-32alpha with nanomolar affinity (independent of catalytic activity) while also proteolytically enhancing IL-32 bioactivity, catalyzes histone H3 N-terminal cleavage (H3ΔN) in monocytes to regulate chromatin accessibility during monocyte-to-macrophage differentiation, and whose expression level is genetically regulated (membrane expression controlled independently of intracellular content), with expression suppression by antisense approaches causing growth arrest and differentiation of myeloid progenitor cells.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"PRTN3 encodes proteinase 3 (PR3), a neutrophil serine protease that functions both as an extracellular protease degrading substrates such as elastin and IgG, and as a nuclear protease that cleaves the amino terminus of histone H3 to regulate chromatin accessibility during monocyte-to-macrophage differentiation [PMID:34017121, PMID:7621597]. PR3 is stored in azurophil granules and can translocate to the cell surface of cytokine-activated endothelial cells, where it serves as the target antigen of C-ANCA autoantibodies in granulomatosis with polyangiitis (Wegener's); these anti-PR3 antibodies block PR3 complexation with its physiological inhibitor alpha-1-antitrypsin, prime CD14-dependent leukocyte activation with NF-κB-dependent cytokine production, and mediate ADCC-dependent endothelial cytotoxicity [PMID:8370167, PMID:8082300, PMID:10583443, PMID:16006536]. In monocytes, PR3 catalyzes histone H3 amino-terminal cleavage (H3ΔN), and simultaneous depletion of PR3 with other neutrophil serine proteases abolishes H3ΔN and increases chromatin accessibility, priming chromatin for gene-expression reprogramming during differentiation [PMID:34017121].\",\n  \"teleology\": [\n    {\n      \"year\": 1993,\n      \"claim\": \"Establishing that anti-PR3 autoantibodies (C-ANCA) functionally disrupt the PR3–alpha-1-antitrypsin inhibitor complex revealed a direct mechanism by which ANCA could perpetuate unopposed PR3 protease activity in vivo.\",\n      \"evidence\": \"In vitro PR3–alpha1AT complexation assays with serial sera from Wegener's granulomatosis patients correlated with disease activity\",\n      \"pmids\": [\"8370167\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether ANCA-mediated inhibitor blockade occurs in vivo at tissue sites\", \"Structural basis of how ANCA epitopes overlap with the alpha1AT binding interface\"]\n    },\n    {\n      \"year\": 1994,\n      \"claim\": \"Demonstrating that PR3 translocates to the surface of TNF-α-activated endothelial cells and that anti-PR3 antibodies mediate ADCC-dependent killing established a direct pathogenic mechanism linking C-ANCA to vascular damage.\",\n      \"evidence\": \"Chromium-51 release cytotoxicity assay with cytokine-primed neutrophils and endothelial cells; inhibition with purified PR3 antigen\",\n      \"pmids\": [\"8082300\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of PR3 translocation to the endothelial surface\", \"Relative contribution of ADCC vs complement-mediated lysis in vivo\"]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Showing that PR3 proteolytically cleaves all human IgG subclasses, including ANCA-IgG bound to PR3, expanded the known substrate repertoire of PR3 beyond elastin to immunoglobulins.\",\n      \"evidence\": \"In vitro proteolysis assay with purified PR3 and IgG subclass proteins; gel electrophoresis of digestion products\",\n      \"pmids\": [\"7621597\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Physiological relevance of IgG cleavage in inflammatory foci\", \"Cleavage site specificity on IgG compared to other serine proteases\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Characterization of the mouse Prtn3 gene confirmed conservation of the catalytic triad, established the five-exon genomic structure, and revealed close chromosomal linkage with neutrophil elastase, enabling subsequent genetic studies.\",\n      \"evidence\": \"cDNA cloning, FISH chromosomal mapping to mouse 10C2, promoter sequence analysis\",\n      \"pmids\": [\"9925946\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional differences between mouse and human PR3 in substrate specificity\", \"Whether promoter elements identified are sufficient for myeloid-restricted expression\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Identifying that anti-PR3 antibodies activate NF-κB and induce IL-8 synthesis in cytokine-primed endothelial cells provided a signaling mechanism linking surface PR3 engagement to proinflammatory gene expression.\",\n      \"evidence\": \"RT-PCR, ELISA, NF-κB p65 nuclear translocation by Western blot, cycloheximide inhibition in primed HUVECs\",\n      \"pmids\": [\"10583443\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Receptor or signaling intermediate linking surface PR3 crosslinking to NF-κB activation\", \"Whether this pathway operates in non-endothelial cell types\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Demonstrating that anti-PR3 antibodies prime monocytes and neutrophils by upregulating CD14, thereby amplifying TLR-dependent cytokine release, revealed a mechanism for ANCA-mediated innate immune amplification.\",\n      \"evidence\": \"In vitro stimulation assays with patient-derived ANCA-IgG; ELISA for IL-8/TNF-α/IL-6; flow cytometry for CD14\",\n      \"pmids\": [\"16006536\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Signaling pathway from anti-PR3 engagement to CD14 transcriptional upregulation\", \"Whether membrane-bound PR3 catalytic activity is required for this priming\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Discovery of CD4+ Th1 memory T cells reactive to complementary-PR3 (encoded by antisense PR3 RNA) in ANCA patients introduced the theory of autoimmunity through complementary proteins, broadening the immunological context of PR3.\",\n      \"evidence\": \"T cell proliferation and IFN-γ secretion assays with cPR3 peptide; scrambled peptide controls; comparison with MPO-ANCA patients\",\n      \"pmids\": [\"18596726\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether cPR3 protein is actually expressed endogenously\", \"Role of cPR3-reactive T cells in disease initiation versus propagation\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Identification of PR3 as a histone H3 amino-terminal protease in monocytes fundamentally expanded its function from an extracellular/granule protease to a chromatin regulator controlling epigenetic reprogramming during monocyte-to-macrophage differentiation.\",\n      \"evidence\": \"siRNA depletion of PRTN3/CTSG/ELANE in monocytic cells; ChIP-seq, ATAC-seq, and mass spectrometry for H3ΔN in primary monocytes and macrophages\",\n      \"pmids\": [\"34017121\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether PRTN3 alone is sufficient for H3ΔN or requires other NSPs cooperatively\", \"Specific histone H3 cleavage site and structural determinants of recognition\", \"Whether H3 cleavage by PR3 occurs in other myeloid lineages\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include whether PR3's catalytic activity is required for its cell-surface signaling functions, the structural basis of PR3–histone H3 recognition, and the individual contribution of PR3 versus other neutrophil serine proteases to chromatin remodeling in vivo.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structural model of PR3–histone H3 complex\", \"Individual genetic knockout of PRTN3 has not been tested for H3ΔN loss in vivo\", \"Whether catalytic-dead PR3 retains surface-mediated proinflammatory signaling\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 3]},\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [0, 1, 3]},\n      {\"term_id\": \"GO:0042393\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [2]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [2, 4]},\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [1, 3]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [4, 6]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [0]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [4, 6]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"SERPINA1\",\n      \"CTSG\",\n      \"ELANE\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"PRTN3 encodes proteinase 3 (PR3/myeloblastin), a neutrophil serine proteinase with elastase-like specificity that functions as a multifaceted effector of innate immunity, inflammation, and myeloid cell fate. Stored in azurophil granules and secretory vesicles, PR3 degrades extracellular matrix proteins (fibronectin, laminin, vitronectin, collagen IV), generates the antimicrobial peptide LL-37 by cleaving hCAP-18, and processes pro-inflammatory cytokines TNF-α, IL-1β, and IL-18 through converting enzyme/caspase-1–independent pathways [PMID:2033050, PMID:11389039, PMID:10339575, PMID:11714826]. PR3 also binds IL-32α with nanomolar affinity independently of catalytic activity and proteolytically enhances IL-32 bioactivity [PMID:16488976], and catalyzes histone H3 N-terminal cleavage in monocytes to regulate chromatin accessibility during monocyte-to-macrophage differentiation [PMID:34017121]. PR3 is the major target autoantigen of c-ANCA in granulomatosis with polyangiitis (Wegener's granulomatosis), where genetically determined membrane PR3 expression—controlled independently of intracellular content—is a risk factor for disease relapse, and a functional PRTN3 locus variant contributes to disease susceptibility [PMID:2679910, PMID:12506139, PMID:28029757].\",\n  \"teleology\": [\n    {\n      \"year\": 1989,\n      \"claim\": \"Identification of PR3 as a novel neutrophil serine proteinase and the c-ANCA autoantigen in Wegener's granulomatosis established the molecular identity of the protein and its disease relevance simultaneously.\",\n      \"evidence\": \"Affinity purification from neutrophils, DFP binding, N-terminal sequencing, Western blot with monoclonal antibodies\",\n      \"pmids\": [\"2679910\", \"2377228\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Enzymatic specificity and substrate repertoire not yet defined\", \"Subcellular localization beyond azurophil granules unknown\", \"No structural model available\"]\n    },\n    {\n      \"year\": 1989,\n      \"claim\": \"Demonstrating that antisense suppression of myeloblastin causes growth arrest and differentiation of myeloid progenitors revealed a non-proteolytic role in maintaining the proliferative state of myeloid cells.\",\n      \"evidence\": \"Antisense oligodeoxynucleotide knockdown in HL-60 cells with proliferation and differentiation assays\",\n      \"pmids\": [\"2598267\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism linking PR3 expression to proliferative maintenance not elucidated\", \"Whether catalytic activity is required for this function is unknown\"]\n    },\n    {\n      \"year\": 1991,\n      \"claim\": \"Biochemical characterization of PR3's substrate specificity (preference for small aliphatic P1 residues) and inhibitor profile (inhibited by α1-antitrypsin and α2-macroglobulin but not SLPI) distinguished it from neutrophil elastase and cathepsin G, defining its unique proteolytic niche.\",\n      \"evidence\": \"In vitro enzymatic assays with chromogenic substrates, ECM protein degradation, inhibitor profiling\",\n      \"pmids\": [\"2033050\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo substrates beyond ECM not yet identified\", \"Physiological contexts of proteolysis unclear\"]\n    },\n    {\n      \"year\": 1992,\n      \"claim\": \"Mapping the PRTN3/ELA2/AZU locus on chromosome 19pter and demonstrating coordinate down-regulation during differentiation established the genomic organization and transcriptional co-regulation of neutrophil serine protease genes.\",\n      \"evidence\": \"Cosmid cloning, FISH, Northern blot during U937 differentiation\",\n      \"pmids\": [\"1518849\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific promoter elements driving PR3 transcription not fully defined\", \"Whether coordinate regulation extends to protein-level control unknown\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"The 2.2 Å crystal structure revealed the chymotrypsin-fold architecture and the S1 pocket residues (Val190→Ile, Ala213→Asp) that dictate small aliphatic P1 preference, providing the first structural explanation for PR3's distinctive specificity.\",\n      \"evidence\": \"X-ray crystallography at 2.2 Å resolution with molecular replacement\",\n      \"pmids\": [\"8757293\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No substrate-bound or inhibitor-bound co-crystal structures\", \"Structural basis for membrane association not addressed\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Discovery that PR3 is stored in secretory vesicles (the most mobilizable pool) in addition to azurophil granules, and that membrane PR3 increases sequentially upon stimulation, resolved how PR3 reaches the cell surface and distinguished its trafficking from elastase.\",\n      \"evidence\": \"Subcellular fractionation, immunoelectron microscopy, FACS after fMLP stimulation\",\n      \"pmids\": [\"10498622\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular mechanism of membrane anchoring (apparently covalent) not identified\", \"Sorting signal directing PR3 to secretory vesicles unknown\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Identification of PR3 as a converting enzyme–independent processor of TNF-α and IL-1β from monocytic cells established an alternative pro-inflammatory cytokine activation pathway distinct from TACE and caspase-1.\",\n      \"evidence\": \"Neutrophil-monocyte co-culture with purified PR3, specific serine protease inhibitors, ELISA\",\n      \"pmids\": [\"10339575\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cleavage sites on TNF-α and IL-1β not mapped\", \"Relative contribution versus canonical processing in vivo unknown\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"PR3 was identified as the sole protease responsible for cleaving hCAP-18 to generate the antimicrobial peptide LL-37 after neutrophil exocytosis, establishing a specific antimicrobial effector function.\",\n      \"evidence\": \"Immunoelectron microscopy, comparison of purified NE/PR3/cathepsin G, immunoblotting of exocytosed material\",\n      \"pmids\": [\"11389039\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether PR3 processes other antimicrobial precursors unknown\", \"In vivo validation in infection models not reported\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Twin studies demonstrating that membrane PR3 expression is genetically determined (r=0.99 in monozygotic twins) and independent of intracellular PR3 content revealed that membrane targeting is under separate genetic control, explaining inter-individual variation in ANCA-vasculitis susceptibility.\",\n      \"evidence\": \"FACS in 27 monozygotic vs. dizygotic twin pairs, intracellular flow cytometry, Western blot\",\n      \"pmids\": [\"12506139\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Causal genetic variant(s) controlling membrane targeting not identified at this time\", \"Whether membrane PR3 has distinct functional properties versus granule PR3 unknown\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Demonstration that PR3 binds IL-32α with nanomolar affinity independent of catalytic activity, while also proteolytically enhancing IL-32 bioactivity, revealed a dual catalytic/non-catalytic mechanism for amplifying cytokine signaling.\",\n      \"evidence\": \"Surface plasmon resonance, enzymatic inactivation, IL-32α affinity chromatography, cytokine induction assays\",\n      \"pmids\": [\"16488976\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis for non-catalytic IL-32 binding unknown\", \"In vivo relevance of PR3–IL-32 axis not established\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"A GWAS identified a functional PRTN3 locus variant that increases neutrophil PRTN3 expression and contributes to ANCA-associated vasculitis susceptibility, providing the genetic link between expression level and disease risk.\",\n      \"evidence\": \"GWAS in 1,986 AAV cases and 4,723 controls with eQTL analysis in primary neutrophils\",\n      \"pmids\": [\"28029757\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Specific causal variant and regulatory mechanism not fully resolved\", \"How expression level interacts with membrane targeting genetics is unclear\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Identification of SERPINB1 as a dual checkpoint that limits PR3 activity via its reactive center loop and independently constrains inflammatory caspases via a CARD-binding motif placed PR3 within a broader intracellular protease control network.\",\n      \"evidence\": \"SERPINB1 knockout mice, domain mutagenesis, siRNA knockdown, protease activity and IL-1β release assays\",\n      \"pmids\": [\"30692621\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether SERPINB1 is the primary intracellular PR3 inhibitor in neutrophils versus monocytes not distinguished\", \"Relative contribution of PR3 versus NE/CatG to SERPINB1-regulated phenotypes not fully separated\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Discovery that PR3 (with NE and CatG) catalyzes histone H3 N-terminal cleavage in monocytes, regulating chromatin accessibility and gene expression reprogramming during monocyte-to-macrophage differentiation, revealed an unexpected nuclear/epigenomic function.\",\n      \"evidence\": \"NSP depletion, ChIP-seq, ATAC-seq, primary monocyte differentiation, systemic JIA patient monocytes\",\n      \"pmids\": [\"34017121\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Individual contribution of PR3 versus NE and CatG to H3ΔN not fully dissected\", \"Mechanism of PR3 nuclear import not established\", \"Whether H3ΔN activity extends to other cell lineages unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The mechanism by which PR3 is targeted to the plasma membrane independently of intracellular content, and the structural determinants of its non-catalytic IL-32 binding, remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Membrane anchoring mechanism (GPI-anchor versus transmembrane partner) not definitively identified\", \"No co-crystal structure of PR3 with IL-32\", \"In vivo contribution of individual PR3 functions (antimicrobial, cytokine processing, chromatin remodeling) to host defense not separately quantified\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 5, 10, 14, 15, 16, 21, 25]},\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [0, 5, 9, 10]},\n      {\"term_id\": \"GO:0042393\", \"supporting_discovery_ids\": [25]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [12]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [12, 18, 19]},\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [5, 15]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [25]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [0, 14, 15, 16, 20, 24, 25]},\n      {\"term_id\": \"R-HSA-1474244\", \"supporting_discovery_ids\": [5]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [25]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [7, 18, 23]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"IL32\",\n      \"SERPINB1\",\n      \"SERPINA1\",\n      \"CAMP\",\n      \"IL1B\",\n      \"TNF\",\n      \"ELANE\",\n      \"CTSG\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}